# EDGAR Filing Document

**Accession Number:** 0000356037
**File Stem:** 0000356037-26-000027
**Filing Date:** 2026-5
**Character Count:** 139239
**Document Hash:** 7a2005cfe467ddf4f583dd203b20c00c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000356037-26-000027.hdr.sgml**: 20260507

**ACCESSION NUMBER**: 0000356037-26-000027

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 81

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260507

**DATE AS OF CHANGE**: 20260507

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CSP INC /MA/
- **CENTRAL INDEX KEY:** 0000356037
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 042441294
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-10843
- **FILM NUMBER:** 26951995

**BUSINESS ADDRESS:**
- **STREET 1:** 175 CABOT STREET
- **STREET 2:** SUITE 210
- **CITY:** LOWELL
- **STATE:** MA
- **ZIP:** 01854
- **BUSINESS PHONE:** 9789545038

**MAIL ADDRESS:**
- **STREET 1:** 175 CABOT STREET
- **STREET 2:** SUITE 210
- **CITY:** LOWELL
- **STATE:** MA
- **ZIP:** 01854

?xml version='1.0' encoding='ASCII'? CSP Inc_March 31, 2026

[**Table of Contents**](#TOC)

**United States**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

**⌧&nbsp;&nbsp;&nbsp;&nbsp;QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the Quarterly Period Ended&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; March 31, 2026**

**or**

◻**&nbsp;&nbsp;&nbsp;&nbsp;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.**

**Commission File Number 000-10843**

**CSP Inc.**

**(Exact name of Registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Massachusetts** | **04-2441294** |
| **(State or other jurisdiction of incorporation or organization)** | **(I.R.S. Employer Identification No.)** |
| **175 Cabot Street - Suite 210, Lowell, MA** | **01854** |
| **(Address of principle executive offices)** | **(Zip Code)** |

---

**(978)-954-5038**

**(Registrant's telephone number, including area code)**

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ⌧&nbsp;&nbsp;&nbsp;&nbsp;No ◻.

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ⌧&nbsp;&nbsp;&nbsp;&nbsp;No ◻.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer" "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ◻ | Accelerated filer | ◻ |
| Non-accelerated filer | ⌧ | Smaller reporting company | ⌧ |
| Emerging growth company | ☐ |  |  |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ◻&nbsp;&nbsp;&nbsp;&nbsp;No ⌧

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.01 per share<br>| CSPI<br>| Nasdaq Global Market<br>|

---

As of May 5, 2026, the registrant had 10,071,847 shares of common stock issued and outstanding.

------

[**Table of Contents**](#TOC)

**INDEX**

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
| [PART I.](#Part1) | [FINANCIAL INFORMATION](#Part1) |  |
| [Item 1.](#Item1) | [Financial Statements](#Item1) |  |
|  | [Condensed Consolidated Balance Sheets as of March 31, 2026 (unaudited) and September 30, 2025](#BALANCESHEETS)  | 3 |
|  | [Condensed Consolidated Statements of Operations for the three and six months ended March 31, 2026 and 2025 (unaudited)](#STATEMENTSOFOPERATIONS) | 4 |
|  | [Condensed Consolidated Statements of Comprehensive Income for the three and six months ended March 31, 2026 and 2025 (unaudited)](#COMPREHENSIVELOSS) | 5 |
|  | [Condensed Consolidated Statement of Shareholders' Equity for the three and six months ended March 31, 2026 and 2025 (unaudited)](#SHAREHOLDEREQUITY) | 6 |
|  | [Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2026 and 2025 (unaudited)](#CASHFLOWS) | 8 |
|  | [Notes to Condensed Consolidated Financial Statements (unaudited)](#NOTESCONSOLIDATEDFINANCIALSTATEMENTS) | 10 |
| [Item 2.](#ITEM2MDA) | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#ITEM2MDA) | 28 |
| [Item 4.](#Item4ControlsAndProcedures) | [Controls and Procedures](#Item4ControlsAndProcedures) | 38 |
| [PART II.](#_PART_II._)  | [OTHER INFORMATION](#_PART_II._) |  |
| [Item 1A.](#Item1ARiskFactors) | [Risk Factors](#Item1ARiskFactors) | 39 |
| [Item 2.](#Item2UnregisteredSalesOfEquitySecurities) | [Unregistered Sales of Equity Securities and Use of Proceeds](#Item2UnregisteredSalesOfEquitySecurities) | 39 |
| [Item 5.](#Itemt5OtherInfo) | [Other Information](#Itemt5OtherInfo) | 39 |
| [Item 6.](#Item6Exhibit) | [Exhibits](#Item6Exhibit) | 40 |

---

[**Table of Contents**](#TOC)

**PART I. FINANCIAL INFORMATION**

#### Item 1. Financial Statements

#### CSP INC. AND SUBSIDIARIES

#### CONDENSED CONSOLIDATED BALANCE SHEETS
**(Amounts in thousands, except par value)**

---

| | | |
|:---|:---|:---|
|  | **March 31,** <br>**2026** | **September 30,**<br>**2025** |
|  | **(Unaudited)** |  |
| **ASSETS** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $23101 | $27418 |
| &nbsp;&nbsp;Accounts receivable, net of allowances of $165 and $122 | 13550 | 12000 |
| &nbsp;&nbsp;Financing receivables, net of allowances of $41 and $34 | 7730 | 8939 |
| &nbsp;&nbsp;Inventories | 1546 | 1442 |
| &nbsp;&nbsp;Refundable income taxes | 311 |  |
| &nbsp;&nbsp;Other current assets | 2806 | 2521 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 49044 | 52320 |
| &nbsp;&nbsp;Property, equipment and improvements, net | 531 | 539 |
| &nbsp;&nbsp;Operating lease right-of-use assets, net | 1440 | 1647 |
| &nbsp;&nbsp;Intangibles, net | 64 | 69 |
| &nbsp;&nbsp;Financing receivables due after one year, net of allowances of $119 and $66 | 8631 | 5965 |
| &nbsp;&nbsp;Deferred income taxes, net | 4428 | 4559 |
| &nbsp;&nbsp;Cash surrender value of life insurance | 5988 | 5845 |
| &nbsp;&nbsp;Pension benefits assets |  | 42 |
| &nbsp;&nbsp;Other assets | 191 | 177 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $70317 | $71163 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;Accounts payable and accrued expenses | $15823 | $19508 |
| &nbsp;&nbsp;Line of credit | 867 | 903 |
| &nbsp;&nbsp;Deferred revenue and contract liabilities | 1777 | 1503 |
| &nbsp;&nbsp;Pension and retirement plans | 93 | 77 |
| &nbsp;&nbsp;Income taxes payable |  | 192 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 18560 | 22183 |
| Pension and retirement plans | 1184 | 1219 |
| Operating lease liabilities - noncurrent portion | 1207 | 1336 |
| Income taxes payable | 150 | 165 |
| Other noncurrent liabilities | 4197 | 1709 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 25298 | 26612 |
| Shareholders' equity: |  |  |
| &nbsp;&nbsp;Common stock, $.01 par value per share; authorized, 20,000 shares; issued and outstanding 10,072 and 9,906 shares, respectively | 101 | 99 |
| &nbsp;&nbsp;Additional paid-in capital | 25676 | 24744 |
| &nbsp;&nbsp;Retained earnings | 27317 | 27700 |
| &nbsp;&nbsp;Accumulated other comprehensive loss | (8075) | (7992) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 45019 | 44551 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $70317 | $71163 |

---

**See accompanying notes to unaudited condensed consolidated financial statements.**

[**Table of Contents**](#TOC)

#### CSP INC. AND SUBSIDIARIES

#### CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
**(Amounts in thousands, except for per share data)**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended**  | **Three months ended**  | **Six Months Ended**  | **Six Months Ended**  |
|  | **March 31,** <br>**2026** | **March 31,** <br>**2025** | **March 31,** <br>**2026** | **March 31,** <br>**2025** |
| **Sales:** |  |  |  |  |
| &nbsp;&nbsp;Product | $11113 | $8552 | $17814 | $19567 |
| &nbsp;&nbsp;Services | 4899 | 4595 | 10234 | 9250 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | 16012 | 13147 | 28048 | 28817 |
| **Cost of sales:** |  |  |  |  |
| &nbsp;&nbsp;Product | 9398 | 6879 | 14680 | 15998 |
| &nbsp;&nbsp;Services | 2142 | 2061 | 4161 | 4048 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cost of sales | 11540 | 8940 | 18841 | 20046 |
| &nbsp;&nbsp;Gross profit | 4472 | 4207 | 9207 | 8771 |
| **Operating expenses:** |  |  |  |  |
| &nbsp;&nbsp;Research and development | 818 | 763 | 1676 | 1549 |
| &nbsp;&nbsp;Selling, general and administrative | 4505 | 4438 | 8494 | 8570 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 5323 | 5201 | 10170 | 10119 |
| **Operating loss** | (851) | (994) | (963) | (1348) |
| **Other income (expense):** |  |  |  |  |
| &nbsp;&nbsp;Foreign exchange gain (loss) | 70 | (132) | 63 | 163 |
| &nbsp;&nbsp;Interest expense | (167) | (77) | (295) | (154) |
| &nbsp;&nbsp;Interest income | 527 | 414 | 1128 | 903 |
| &nbsp;&nbsp;Other income (expense), net | 117 | (2) | 134 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other income, net | 547 | 203 | 1030 | 914 |
| &nbsp;&nbsp;&nbsp;&nbsp;(Loss) income before income taxes | (304) | (791) | 67 | (434) |
| &nbsp;&nbsp;Income tax benefit | (568) | (683) | (288) | (798) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss)  | $264 | $(108) | $355 | $364 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to common shareholders | $255 | $(108) | $339 | $341 |
| &nbsp;&nbsp;Net income (loss) per common share - basic | $0.03 | $(0.01) | $0.04 | $0.04 |
| &nbsp;&nbsp;Weighted average common shares outstanding - basic | 9552 | 9343 | 9461 | 9232 |
| &nbsp;&nbsp;Net income (loss) per common share - diluted | $0.03 | $(0.01) | $0.04 | $0.04 |
| &nbsp;&nbsp;Weighted average common shares outstanding - diluted | 9713 | 9343 | 9662 | 9614 |

---

**See accompanying notes to unaudited condensed consolidated financial statements.**

[**Table of Contents**](#TOC)

#### CSP INC. AND SUBSIDIARIES

#### CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

#### (Amounts in thousands)
(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended**  | **Three months ended**  | **Six Months Ended**  | **Six Months Ended**  |
|  | **March 31,** <br>**2026** | **March 31,** <br>**2025** | **March 31,** <br>**2026** | **March 31,** <br>**2025** |
| Net income (loss) | $264 | $(108) | $355 | $364 |
| Other comprehensive (loss) income: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation (loss) gain adjustments, net of tax effect | (87) | 238 | (83) | (258) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive (loss) income | (87) | 238 | (83) | (258) |
| Total comprehensive income | $177 | $130 | $272 | $106 |

---

**See accompanying notes to unaudited condensed consolidated financial statements.**

[**Table of Contents**](#TOC)

#### CSP INC. AND SUBSIDIARIES

#### CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
**For the three months ended March 31, 2026 and 2025**

**(Amounts in thousands, except per share data)**

**(Unaudited)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Three months ended March 31, 2026** | <br>**Shares** | <br>**Amount** | <br>**Additional**<br>**Paid-in**<br>**Capital** | <br>**Retained**<br>**Earnings** | **Accumulated**<br>**other**<br>**comprehensive**<br>**loss** | <br>**Total**<br>**Shareholders'**<br>**Equity** |
| Balance as of December 31, 2025 | 9905 | $99 | $25207 | $27492 | $(7988) | $44810 |
| Net income |  |  |  | 264 |  | 264 |
| Other comprehensive loss |  |  |  |  | (87) | (87) |
| Stock-based compensation |  |  | 390 |  |  | 390 |
| Restricted stock issuance | 175 | 2 |  |  |  | 2 |
| Issuance of shares under employee stock purchase plan | 8 |  | 79 |  |  | 79 |
| Repurchase of common stock | (16) |  |  | (139) |  | (139) |
| Cash dividends paid on common stock ($0.03 per share) |  |  |  | (300) |  | (300) |
| Balance as of March 31, 2026 | 10072 | $101 | $25676 | $27317 | $(8075) | $45019 |
|  |  |  |  |  | **Accumulated** |  |
|  |  |  | **Additional** |  | **other** | **Total** |
|  |  |  | **Paid-in** | **Retained** | **comprehensive** | **Shareholders'** |
| **Three months ended March 31, 2025** | **Shares** | **Amount** | **Capital** | **Earnings** | **loss** | **Equity** |
| Balance as of December 31, 2024 | 9880 | $98 | $23196 | $30023 | $(5861) | $47456 |
| Net loss |  |  |  | (108) |  | (108) |
| Other comprehensive income |  |  |  |  | 238 | 238 |
| Stock-based compensation |  |  | 448 |  |  | 448 |
| Restricted stock issuance | 1 |  |  |  |  |  |
| Issuance of shares under employee stock purchase plan | 6 |  | 99 |  |  | 99 |
| Repurchase of common stock | (24) |  |  | (384) |  | (384) |
| Cash dividends paid on common stock ($0.03 per share) |  |  |  | (296) |  | (296) |
| Balance as of March 31, 2025 | 9863 | $98 | $23743 | $29235 | $(5623) | $47453 |

---

**See accompanying notes to unaudited condensed consolidated financial statements.**

[**Table of Contents**](#TOC)

#### CSP INC. AND SUBSIDIARIES

#### CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
**For the six months ended March 31, 2026 and 2025**

**(Amounts in thousands, except per share data)**

**(Unaudited)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Six months ended March 31, 2026:** | <br>**Shares** | <br>**Amount** | <br>**Additional**<br>**Paid-in**<br>**Capital** | <br>**Retained**<br>**Earnings** | **Accumulated**<br>**other**<br>**comprehensive**<br>**loss** | <br>**Total**<br>**Shareholders'**<br>**Equity** |
| Balance as of September 30, 2025 | 9906 | $99 | $24744 | $27700 | $(7992) | $44551 |
| Net income |  |  |  | 355 |  | 355 |
| Other comprehensive loss |  |  |  |  | (83) | (83) |
| Stock-based compensation |  |  | 853 |  |  | 853 |
| Restricted stock cancellation | (1) |  |  |  |  |  |
| Restricted stock issuance | 175 | 2 |  |  |  | 2 |
| Issuance of shares under employee stock purchase plan | 8 |  | 79 |  |  | 79 |
| Repurchase of common stock | (16) |  |  | (139) |  | (139) |
| Cash dividends paid on common stock ($0.06 per share) |  |  |  | (599) |  | (599) |
| Balance as of March 31, 2026 | 10072 | $101 | $25676 | $27317 | $(8075) | $45019 |
|  |  |  |  |  | **Accumulated** |  |
|  |  |  | **Additional** |  | **other** | **Total** |
|  |  |  | **Paid-in** | **Retained** | **comprehensive** | **Shareholders'** |
| **Six months ended March 31, 2025:** | **Shares** | **Amount** | **Capital** | **Earnings** | **loss** | **Equity** |
| Balance as of September 30, 2024 | 9776 | $98 | $22689 | $29848 | $(5365) | $47270 |
| Net income |  |  |  | 364 |  | 364 |
| Other comprehensive loss |  |  |  |  | (258) | (258) |
| Stock-based compensation |  |  | 955 |  |  | 955 |
| Restricted stock issuance | 105 |  |  |  |  |  |
| Issuance of shares under employee stock purchase plan | 6 |  | 99 |  |  | 99 |
| Repurchase of common stock | (24) |  |  | (384) |  | (384) |
| Cash dividends paid on common stock ($0.06 per share) |  |  |  | (593) |  | (593) |
| Balance as of March 31, 2025 | 9863 | $98 | $23743 | $29235 | $(5623) | $47453 |

---

**See accompanying notes to unaudited condensed consolidated financial statements.**

[**Table of Contents**](#TOC)

#### CSP INC. AND SUBSIDIARIES

#### CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
**(Amounts in thousands)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended**  | **Six Months Ended**  |
|  | **March 31,** <br>**2026** | **March 31,** <br>**2025** |
| **Operating activities** |  |  |
| Net income | $355 | $364 |
| Adjustments to reconcile net income to net cash (used in) provided by operating activities: |  |  |
| &nbsp;&nbsp;Depreciation | 126 | 119 |
| &nbsp;&nbsp;Amortization of intangibles | 4 | 3 |
| &nbsp;&nbsp;Loss on disposal of fixed assets, net | 1 | 1 |
| &nbsp;&nbsp;Foreign exchange gain | (63) | (163) |
| &nbsp;&nbsp;Provision for credit losses - financing receivables | 60 | 52 |
| &nbsp;&nbsp;Provision (benefit) for credit losses - accounts receivable | 47 | (16) |
| &nbsp;&nbsp;Provision for obsolete inventory |  | 46 |
| &nbsp;&nbsp;Amortization of lease right-of-use assets | 207 | 258 |
| &nbsp;&nbsp;Stock-based compensation expense on restricted stock awards | 853 | 955 |
| &nbsp;&nbsp;Deferred income taxes | 131 | (828) |
| &nbsp;&nbsp;Increase in cash surrender value of life insurance | (89) | (54) |
| &nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (1606) | 866 |
| &nbsp;&nbsp;&nbsp;&nbsp;Financing receivables | (1517) | 863 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | (104) | 137 |
| &nbsp;&nbsp;&nbsp;&nbsp;Refundable income taxes | (308) | (468) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | (299) | 1182 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | (3606) | 91 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | (175) | (257) |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue and contract liabilities | 274 | 297 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension and retirement plans | 22 | (679) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | (210) | (226) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other noncurrent liabilities | 2488 | 1110 |
| Net cash (used in) provided by operating activities | (3409) | 3653 |
| **Investing activities** |  |  |
| &nbsp;&nbsp;Life insurance premiums paid | (54) | (54) |
| &nbsp;&nbsp;Purchases of property, equipment and improvements | (119) | (54) |
| Net cash used in investing activities | (173) | (108) |
| **Financing activities** |  |  |
| &nbsp;&nbsp;Dividends paid | (599) | (593) |
| &nbsp;&nbsp;Net repayment under line-of-credit agreement | (36) | (3725) |
| &nbsp;&nbsp;Repurchases of common stock | (139) | (384) |
| &nbsp;&nbsp;Proceeds from issuance of shares under equity compensation plans | 79 | 99 |
| Net cash used in financing activities | (695) | (4603) |
| Effects of exchange rate on cash, net | (40) | (32) |
| Net decrease in Cash and cash equivalents | (4317) | (1090) |
| Cash and cash equivalents beginning of period | 27418 | 30585 |
| **Cash and cash equivalents end of period** | $23101 | $29495 |

---

**See accompanying notes to unaudited condensed consolidated financial statements.**

[**Table of Contents**](#TOC)

---

| | | |
|:---|:---|:---|
| **Supplementary cash flow information:** |  |  |
| Cash paid for income taxes | $254 | $724 |
| Cash paid for interest | $68 | $36 |
| **Supplementary non-cash financing activities:** |  |  |
| Obtaining a right-of-use asset in exchange for a lease liability | $— | $247 |
| Customer financing for inventory sold (see *Note 5 Financing receivables, net* for details) | $6893 | $2006 |
| Vendor financing for inventory purchased (see *Note 8 Accounts payable and accrued expenses, and Other noncurrent liabilities* for details) | $5820 | $1833 |

---

**See accompanying notes to unaudited condensed consolidated financial statements.**

[**Table of Contents**](#TOC)

#### CSP INC. AND SUBSIDIARIES

#### NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

#### Organization and Business
CSP Inc. ("CSPi" or "CSPI" or "the Company" or "we" or "our") was incorporated in 1968 and is based in Lowell, Massachusetts. CSPi and its subsidiaries develop and market IT integration solutions, advanced security products, managed IT services, purpose built network adapters, and high-performance cluster computer systems to meet the diverse requirements of its commercial and defense customers worldwide. The Company operates in two segments, its Technology Solutions ("TS") segment and High Performance Products ("HPP") segment.

*1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basis of Presentation and Significant Accounting Policies*

#### Basis of Presentation
The accompanying interim condensed consolidated financial statements have been prepared by the Company and reflect all adjustments which, in the opinion of management, are necessary for a fair statement of the results of the interim periods presented. All adjustments were of a normal recurring nature. Certain information and footnote disclosures normally included in the annual consolidated financial statements, which are prepared in accordance with accounting principles generally accepted in the United States, have been omitted.

Accordingly, the Company believes that although the disclosures are adequate to make the information presented not misleading, the unaudited condensed consolidated financial statements should be read in conjunction with the notes contained in the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2025. The significant accounting policies and estimates used in preparing these Condensed Consolidated Financial Statements were applied on a basis consistent with those reflected in the September 30, 2025 Consolidated Financial Statements.

#### Significant Accounting Policies
There have been no significant changes to the Company's significant accounting policies described in PART II, Item 8, *Note 1 Basis of Presentation and Summary of Significant Accounting Policies*, of the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2025.

#### Accounting Pronouncement Not Yet Adopted as of March 31, 2026
In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides new optional guidance relating to the estimation of expected credit losses on current accounts receivable and current contract assets under Topic 326. This ASU permits entities to apply a practical expedient when estimating credit losses and is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted, and should be applied prospectively. We are currently evaluating the adoption of this standard and its impact to the Company's consolidated financial statements and related disclosures.

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income— Expense Disaggregation Disclosures (Subtopic 220-40), which requires expanded disclosures in the notes to the financial statements about certain costs and expenses. This ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, on a retrospective basis. Early adoption is permitted. The Company is currently evaluating the effect of this pronouncement on its disclosures.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU expands existing income tax disclosures primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The ASU is effective for all public entities for annual periods beginning after December 15, 2024, with early adoption permitted. Entities should apply the amendments on a

[**Table of Contents**](#TOC)

prospective basis, but retrospective application is permitted. The Company plans to adopt this ASU on a prospective basis in the fourth quarter of fiscal year 2026. The Company is currently evaluating the impact this ASU will have on its disclosures.

*2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Revenue*

See details of timing of revenue recognition, whether CSPi acted as the principal or agent, and geography below. Geographic areas are based on where the products were shipped or services rendered.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Technology Solutions Segment** | **Technology Solutions Segment** | **Technology Solutions Segment** | |
| <br>**Three months ended March 31,** | <br>**High**<br>**Performance**<br>**Products**<br>**Segment** | <br>**United**<br>**Kingdom** | <br>**U.S.** | <br>**Total** | <br>**Consolidated**<br>**Total** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** |
| **2026** |  |  |  |  |  |
| **Timing of Revenue Recognition** |  |  |  |  |  |
| Transferred at a point in time where CSPi is principal  | $65 | $47 | $11018 | $11065 | $11130 |
| Transferred at a point in time where CSPi is agent |  | 30 | 1780 | 1810 | 1810 |
| Transferred over time where CSPi is principal | 283 |  | 2789 | 2789 | 3072 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | $348 | $77 | $15587 | $15664 | $16012 |
| **Geography** |  |  |  |  |  |
| United States | $332 | $24 | $15148 | $15172 | $15504 |
| Americas (excluding United States) |  |  | 432 | 432 | 432 |
| Europe |  | 51 | 7 | 58 | 58 |
| APAC and Africa | 16 | 2 |  | 2 | 18 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | $348 | $77 | $15587 | $15664 | $16012 |
| **2025** |  |  |  |  |  |
| **Timing of Revenue Recognition** |  |  |  |  |  |
| Transferred at a point in time where CSPi is principal  | $276 | $417 | $7845 | $8262 | $8538 |
| Transferred at a point in time where CSPi is agent |  | 24 | 1444 | 1468 | 1468 |
| Transferred over time where CSPi is principal | 371 | 38 | 2732 | 2770 | 3141 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | $647 | $479 | $12021 | $12500 | $13147 |
| **Geography** |  |  |  |  |  |
| United States | $497 | $21 | $11452 | $11473 | $11970 |
| Americas (excluding United States) | 1 |  | 372 | 372 | 373 |
| Europe |  | 458 | 197 | 655 | 655 |
| APAC and Africa | 149 |  |  |  | 149 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | $647 | $479 | $12021 | $12500 | $13147 |

---

[**Table of Contents**](#TOC)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Technology Solutions Segment** | **Technology Solutions Segment** | **Technology Solutions Segment** | |
| <br>**Six months ended March 31,** | <br>**High**<br>**Performance**<br>**Products**<br>**Segment** | <br>**United**<br>**Kingdom** | <br>**U.S.** | <br>**Total** | <br>**Consolidated**<br>**Total** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** |
| **2026** |  |  |  |  |  |
| **Timing of Revenue Recognition** |  |  |  |  |  |
| Transferred at a point in time where CSPi is principal  | $610 | $70 | $17473 | $17543 | $18153 |
| Transferred at a point in time where CSPi is agent |  | 40 | 3915 | 3955 | 3955 |
| Transferred over time where CSPi is principal | 591 |  | 5349 | 5349 | 5940 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | $1201 | $110 | $26737 | $26847 | $28048 |
| **Geography** |  |  |  |  |  |
| United States | $745 | $34 | $25751 | $25785 | $26530 |
| Americas (excluding United States) |  |  | 924 | 924 | 924 |
| Europe |  | 69 | 59 | 128 | 128 |
| APAC and Africa | 456 | 7 | 3 | 10 | 466 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | $1201 | $110 | $26737 | $26847 | $28048 |
| **2025** |  |  |  |  |  |
| **Timing of Revenue Recognition** |  |  |  |  |  |
| Transferred at a point in time where CSPi is principal  | $358 | $550 | $18760 | $19310 | $19668 |
| Transferred at a point in time where CSPi is agent |  | 24 | 3248 | 3272 | 3272 |
| Transferred over time where CSPi is principal | 719 | 85 | 5073 | 5158 | 5877 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | $1077 | $659 | $27081 | $27740 | $28817 |
| **Geography** |  |  |  |  |  |
| United States | $919 | $93 | $26195 | $26288 | $27207 |
| Americas (excluding United States) | 4 |  | 616 | 616 | 620 |
| Europe |  | 566 | 270 | 836 | 836 |
| APAC and Africa | 154 |  |  |  | 154 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | $1077 | $659 | $27081 | $27740 | $28817 |

---

In the TS US division, financing of goods and services is offered to certain customers. This involves amounts due reflecting sales whose payment terms exceed one year. See *Note 5 Financing Receivables, net* for more details. Revenue from these agreements in the three months ended March 31, 2026 was $417 thousand in which the Company acted as the agent. Revenue from these agreements in the three months ended March 31, 2025 was $142 thousand in which the Company acted as the agent.

Revenue from these agreements in the six months ended March 31, 2026 was $1,072 thousand in which the Company acted as the agent. Revenue from these agreements in the six months ended March 31, 2025 was $165 thousand in which the Company acted as the agent.

***Contract Assets and Liabilities***

When we have performed work but do not have an unconditional right to payment, a contract asset is recorded. When we have the right to bill a customer, accounts receivable is recorded as an unconditional right exists. Current contract assets were $0.7 million and $0.8 million as of March 31, 2026 and September 30, 2025, respectively. Current contract assets were $1.7 million as of September 30, 2024. The current portion is recorded in Other current assets on the condensed consolidated balance sheets. There were no noncurrent contract assets as of March 31, 2026 and September 30, 2025. There were no noncurrent contract assets as of September 30, 2024. The difference in the balances is due to regular timing differences between when work is performed and having an unconditional right to payment.

[**Table of Contents**](#TOC)

Contract liabilities arise when payment is received before we transfer a good or service to the customer. Current contract liabilities were $1.7 million and $1.5 million as of March 31, 2026 and September 30, 2025, respectively. Current contract liabilities were $2.2 million as of September 30, 2024. The current portion of contract liabilities is recorded in Deferred revenue and contract liabilities on the condensed consolidated balance sheets. There were $42 thousand and $37 thousand of long-term contract liabilities as of March 31, 2026 and September 30, 2025, respectively. There were no long-term contract liabilities as of September 30, 2024. Long-term contract liabilities are in Other noncurrent liabilities on the condensed consolidated balance sheets. Revenue recognized for the six months ended March 31, 2026 that was included in contract liabilities as of September 30, 2025 was $0.9 million.

***Contract Costs***

Incremental costs of obtaining a contract involving customer transactions where the revenue and the related transfer of goods and services are equal to or less than a one year period, are expensed as incurred, utilizing the practical expedient in *ASC 340-40-25-4*. For a period greater than one year, incremental contract costs are capitalized if we expect to recover these costs. The costs are amortized over the contract term and expected renewal periods. The period of amortization is generally three years. Incremental costs are related to commissions in the TS portion of the business. In fiscal year 2026 the TS segment paid commissions on a monthly basis for contracts over one year. Current capitalized contract costs are within the Other current assets on the condensed consolidated balance sheets as of March 31, 2026 and September 30, 2025. The portion of current capitalized costs were $25 thousand and $33 thousand as of March 31, 2026 and September 30, 2025, respectively. There are no noncurrent capitalized costs on the condensed consolidated balance sheets. The amount of incremental costs amortized for the three months ended March 31, 2026 and 2025 were $14 thousand and $50 thousand, respectively. The amount of incremental costs amortized for the six months ended March 31, 2026 and 2025 were $24 thousand and $154 thousand, respectively and is recorded in selling, general, and administrative expenses. There was no impairment related to incremental costs capitalized during the six months ended March 31, 2026 and 2025.

***Other***

Projects are typically billed upon completion or at certain milestones. Products and services are typically billed when shipped or as services are being performed. Payment terms are typically 30 days to pay in full except in Europe where it could be up to 90 days. Most of our contracts are less than one year. There are certain contracts that contain a financing component. See *Note 5 Financing receivables, net* to the condensed consolidated financial statements for additional information. We elected to use the optional exemption to not disclose the aggregate amount of the transaction price allocated to performance obligations that have an original expected duration of one year or less. This is due to a low number of performance obligations, which are less than one year from being unsatisfied at each period end. Most of these contracts are related to product sales.

We have certain contracts that have an original term of more than one year. The royalty agreement is longer than one year, but not included in the table below as the royalties are sales-based. Managed service contracts are generally longer than one year and revenue is recognized ratably over the contract term. For these contracts the aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied or partially unsatisfied as of March 31, 2026 is set forth in the table below:

---

| | |
|:---|:---|
| Fiscal Year | (Amounts in thousands) |
| 2026 (remaining 6 months) | $560 |
| 2027 | 982 |
| 2028 | 899 |
| 2029 | 222 |
|  | $2663 |

---

[**Table of Contents**](#TOC)

#### 3 .&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings Per Share of Common Stock
We are required to present earnings per share ("EPS") utilizing the two-class method because we had outstanding, non-vested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents, which are considered participating securities.

Basic net income (loss) per common share is computed by dividing net income attributable to common shareholders by the weighted average number of common shares outstanding for the period. Diluted net income per share includes the dilutive effect of restricted stock awards (RSA's), if any, calculated using the treasury stock method. Using the treasury stock method, the effect of dilutive securities includes the additional shares of common stock that would have been outstanding based on the assumption that these potentially dilutive securities had been issued. The treasury stock method assumes proceeds from the unamortized compensation expense of restricted stock awards are used to repurchase common shares at the average market price during the period, thus reducing the dilutive effect. RSA's with assumed proceeds per unit above the Company's average share price for the periods presented are excluded from the diluted EPS calculation because the effect is anti-dilutive.

Basic and diluted EPS computations for the Company's reported net income attributable to common stockholders are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended**  | **Three months ended**  | **Six Months Ended**  | **Six Months Ended**  |
|  | **March 31,** <br>**2026** | **March 31,** <br>**2025** | **March 31,** <br>**2026** | **March 31,** <br>**2025** |
|  | **(Amounts in thousands except per share data)** | **(Amounts in thousands except per share data)** | **(Amounts in thousands except per share data)** | **(Amounts in thousands except per share data)** |
| Net income (loss) | $264 | $(108) | $355 | $364 |
| Less: net income attributable to nonvested common stock | (9) |  | (16) | (23) |
| Net income (loss) attributable to common shareholders | $255 | $(108) | $339 | $341 |
| Weighted average total shares outstanding - basic | 9913 | 9343 | 9909 | 9851 |
| Less: weighted average non–vested shares outstanding | (361) |  | (448) | (619) |
| Weighted average number of common shares outstanding - basic | 9552 | 9343 | 9461 | 9232 |
| Add: potential common shares from non-vested restricted stock awards | 161 |  | 201 | 382 |
| Weighted average common shares outstanding - diluted | 9713 | 9343 | 9662 | 9614 |
| Net income (loss) per common share - basic | $0.03 | $(0.01) | $0.04 | $0.04 |
| Net income (loss) per common share - diluted | $0.03 | $(0.01) | $0.04 | $0.04 |

---

Anti-dilutive securities include restricted stock awards, which are excluded from the diluted income per share computation. Non-vested restricted stock awards of 141 thousand shares and 269 thousand shares were excluded from net income (loss) per common share - diluted for the three months ended March 31, 2026 and 2025 because their inclusion would have been anti-dilutive. Non-vested restricted stock awards of 114 thousand shares were excluded from net income per share - diluted for the six months ended March 31, 2026 because their inclusion would have been anti-dilutive.

#### 4 .&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net
The Company recognizes an allowance for losses on accounts receivable in an amount equal to the current expected credit losses. The estimation of the allowance is based on an analysis of historical loss experience, management's assessment of current conditions and reasonable and supportable expectation of future conditions as well as an assessment of specific identifiable customer accounts considered at risk or uncollectible including reviewing the current receivables aging. This results in a general reserve and a specific reserve. The Company assesses collectability by pooling receivables where similar characteristics exist and evaluates receivables individually when specific customer balances no longer share

[**Table of Contents**](#TOC)

those risk characteristics and are considered at risk or uncollectible. The expense associated with the allowance for expected credit losses is recognized in Selling, general, and administrative expenses in the Consolidated Statements of Operations.

The following tables present the changes in the allowance for accounts receivable for the periods indicated.

---

| | | |
|:---|:---|:---|
|  | **Three months ended** | **Three months ended** |
|  | **March 31, 2026** | **March 31, 2025** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** |
| *Allowance for credit losses for accounts receivable:* |  |  |
| Balances at beginning of the period | $95 | $153 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Charge-offs | (4) | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision (benefit) for credit losses | 74 | (22) |
| Balances at end of the period | $165 | $131 |

---

---

| | | |
|:---|:---|:---|
|  | **Six months ended**  | **Six months ended**  |
|  | **March 31, 2026** | **March 31, 2025** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** |
| *Allowance for credit losses for accounts receivable:* |  |  |
| Balances at beginning of the period | $122 | $147 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Charge-offs | (4) | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision (benefit) for credit losses | 47 | (16) |
| Balances at end of the period | $165 | $131 |

---

#### 5 .&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financing receivables, net
In the TS U.S. division, financing of goods and services is offered to certain customers. This involves amounts due reflecting sales whose payment terms exceed one year. This financing is separate from agreements with a leasing component, see *Note 7 Leases* for financing through leases. Determining whether to offer financing involves looking at the customer's payment history, economic conditions, and capacity to pay.

The Company assigns an internal risk rating to each customer at inception, which groups customers into a portfolio based off this risk rating. A risk rating is assigned by analyzing a customer's financial statements and the latest Fitch rating if publicly available as well as recent payment activity. The credit quality of customers is continually monitored by these items. Accounts rated low risk have the equivalent of a Fitch rating of BBB– or higher, moderate risk accounts have the equivalent of BB, and high risk accounts have the equivalent of B.

The risk characteristics of each customer are consistent with the Fitch rating or equivalent, which are defined by Fitch as the following:

'BBB' ratings indicate that expectations of default risk are currently low. The capacity for payment of financial commitments is considered adequate, but adverse business or economic conditions are more likely to impair this capacity.

'BB' ratings indicate an elevated vulnerability to default risk, particularly in the event of adverse changes in business or economic conditions over time; however, business or financial flexibility exists that supports the servicing of financial commitments.

'B' ratings indicate that material default risk is present, but a limited margin of safety remains. Financial commitments are currently being met; however, capacity for continued payment is vulnerable to deterioration in the business and economic environment.

[**Table of Contents**](#TOC)

Financing receivables, net, carry an average weighted interest rate of 8.6%, which reflects the approximate interest rate consistent with a separate financing transaction with the customer at the inception of the agreement.

The amount of interest income earned from sales whose payment terms exceed one year for the three months ended March 31, 2026 and 2025 was $320 thousand and $113 thousand, respectively. The amount of interest income earned from sales whose payment terms exceed one year for the six months ended March 31, 2026 and 2025 was $662 thousand and $254 thousand, respectively. Interest income from these agreements is recorded in Other (expense) income, net on the Condensed Consolidated Statements of Operations.

The following table presents the components of the Company's Financing receivables, net segregated by portfolio (risk rating) for the periods indicated:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|  | **Risk Rating** | **Risk Rating** | **Risk Rating** | | **Risk Rating** | **Risk Rating** | **Risk Rating** | |
|  | **Low** | **Moderate** | **High** | <br>**Total** | **Low** | **Moderate** | **High** | <br>**Total** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** |
| *Financing receivables, net:* |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Financing receivables, gross | $13608 | $3135 | $1259 | $18002 | $13651 | $1751 | $891 | $16293 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unearned interest income | (1053) | (333) | (95) | (1481) | (1038) | (156) | (95) | (1289) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Allowance for credit losses | (47) | (64) | (49) | (160) | (50) | (18) | (32) | (100) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financing receivables, net | $12508 | $2738 | $1115 | $16361 | $12563 | $1577 | $764 | $14904 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Short-term | $6065 | $1168 | $497 | $7730 | $7778 | $791 | $370 | $8939 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term | $6443 | $1570 | $618 | $8631 | $4785 | $786 | $394 | $5965 |

---

The following table presents the changes in Allowance for credit losses for Financing receivables, net for the periods indicated:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2025** | **March 31, 2025** | **March 31, 2025** | **March 31, 2025** |
|  | **Risk Rating** | **Risk Rating** | **Risk Rating** | | **Risk Rating** | **Risk Rating** | | |
|  | **Low** | **Moderate** | **High** | <br>**Total** | **Low** | **Moderate** | <br>**High** | <br>**Total** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** |
| *Allowance for credit losses for financing receivables:* |  |  |  |  |  |  |  |  |
| Balances at beginning of the period | $47 | $42 | $32 | $121 | $21 | $8 | $6 | $35 |
| (Benefit) provision charged to Consolidated Statements of Operations | - | 22 | 17 | 39 | 3 | (2) | 53 | 54 |
| Balances at end of the period | $47 | $64 | $49 | $160 | $24 | $6 | $59 | $89 |

---

[**Table of Contents**](#TOC)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Six months ended**  | **Six months ended**  | **Six months ended**  | **Six months ended**  | **Six months ended**  | **Six months ended**  | **Six months ended**  | **Six months ended**  |
|  | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2025** | **March 31, 2025** | **March 31, 2025** | **March 31, 2025** |
|  | **Risk Rating** | **Risk Rating** | **Risk Rating** | | **Risk Rating** | **Risk Rating** | | |
|  | **Low** | **Moderate** | **High** | <br>**Total** | **Low** | **Moderate** | <br>**High** | <br>**Total** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** |
| *Allowance for credit losses for financing receivables:* |  |  |  |  |  |  |  |  |
| Balances at beginning of the period | $50 | $18 | $32 | $100 | $27 | $10 | $- | $37 |
| &nbsp;&nbsp;Provision (benefit) charged to Consolidated Statements of Operations | (3) | 46 | 17 | 60 | (3) | (4) | 59 | 52 |
| Balances at end of the period | $47 | $64 | $49 | $160 | $24 | $6 | $59 | $89 |

---

The Company recognizes an allowance for credit losses for financing receivables in an amount equal to the probable losses net of recoveries. A probability method for calculating credit losses is used based on historical data of defaults of Fitch ratings and length of time. Various factors are also assessed in the allowance for credit losses including internal historical data as well as macroeconomic forecast assumptions and management judgments applicable to and through the expected life of the portfolios. Macroeconomic conditions include the level of gross domestic product ("GDP") growth and unemployment rates, which directly correlate with our historical credit losses. The expense associated with the allowance for expected credit losses is recognized in Selling, general, and administrative expenses in the Consolidated Statements of Operations.

Financing receivables whose payment terms exceed one year are placed on non-accrual status, meaning interest income stops being recorded, when the customer has a past due amount in excess of 30 days or reasonable doubt exists in collecting all interest and principal. A payment due in excess of 30 days is considered delinquent. If a payment is received for a receivable on non-accrual status the payment is first applied to interest and then principal. Recording interest income resumes once no reasonable doubt exists regarding collecting all interest and principal. There were no financing receivables placed on non-accrual status as of March 31, 2026 or September 30, 2025.

The following table presents Financing receivables, gross, including accrued interest and excluding any allowance, by credit quality indicator segregated by risk rating and year of origination as of March 31, 2026:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
| | **Fiscal year of origination** | **Fiscal year of origination** | **Fiscal year of origination** | **Fiscal year of origination** | **Fiscal year of origination** |
| <br>**Risk Rating** | **2026** | **2025** | **2024** | **2023** | **Total** |
| High | $415 | $844 | $— | $— | $1259 |
| Moderate | 1636 | 1268 | 231 |  | 3135 |
| Low | 4516 | 6625 | 1211 | 1256 | 13608 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $6567 | $8737 | $1442 | $1256 | $18002 |

---

[**Table of Contents**](#TOC)

Contractual maturities of outstanding financing receivables are as follows:

---

| | |
|:---|:---|
| **Fiscal year ending September 30:** | **(Amounts in thousands)** |
| 2026 (remaining 6 months) | $5790 |
| 2027 | 7130 |
| 2028 | 3706 |
| 2029 | 1063 |
| 2030 | 313 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total payments | $18002 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: unearned interest income | (1481) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: allowance for credit losses | (160) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total, net of unearned interest income and allowance for credit losses | $16361 |

---

#### 6 .&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories
Inventories consist of the following:

---

| | | |
|:---|:---|:---|
|  | **March 31,** <br>**2026** | **September 30,**<br>**2025** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** |
| Work-in-process | $— | $94 |
| Finished goods | 1546 | 1348 |
| Total | $1546 | $1442 |

---

#### 7 .&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Leases
Information related to both lessee and lessor

The components of lease costs for the three months ended March 31, 2026 and 2025 are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | | **Three months ended** | **Three months ended** |
|  | <br>**Consolidated Statements of Operations Location** | **March 31, 2026** | **March 31, 2025** |
|  |  | **(Amounts in thousands)** | **(Amounts in thousands)** |
| Operating Lease: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease cost | Selling, general, and administrative | $129 | $127 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Short-term lease cost | Selling, general, and administrative | 8 | 7 |
| Total lease costs |  | $137 | $134 |
| Less lessor interest income | Revenue | (1) | (3) |
| Total lease costs, net of lessor interest income |  | $136 | $131 |

---

[**Table of Contents**](#TOC)

The components of lease costs for the six months ended March 31, 2026 and 2025 are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | | **Six months ended**  | **Six months ended**  |
|  | <br>**Consolidated Statements of Operations Location** | **March 31, 2026** | **March 31, 2025** |
|  |  | **(Amounts in thousands)** | **(Amounts in thousands)** |
| Operating Lease: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease cost | Selling, general, and administrative | $259 | $266 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Short-term lease cost | Selling, general, and administrative | 16 | 16 |
| Total lease costs |  | $275 | $282 |
| Less lessor interest income | Revenue | (3) | (4) |
| Total lease costs, net of lessor interest income |  | $272 | $278 |

---

Supplemental cash flow information related to leases for the six months ended March 31, 2026 and 2025 is below:

---

| | | |
|:---|:---|:---|
|  | **Six months ended**  | **Six months ended**  |
|  | **March 31, 2026** | **March 31, 2025** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** |
| Cash paid for amounts included in the measurement of lease liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating cash flows paid for operating leases | $228 | $281 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating cash flows paid for short-term leases | 16 | 16 |
| Cash received from lessor agreements | (23) | (21) |
| Lease assets obtained in exchange for new lease liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases |  | 247 |

---

#### 8 .&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses, and Other noncurrent liabilities
The TS US division enters into certain multi-year agreements with vendors when also entering into some of the multi-year financing contracts the Company enters into with customers. See *Note 5 Financing receivables, net* for further information related to the multi-year agreements with customers.

There was no interest rate stated in the agreements and therefore interest was imputed under *ASC 835 Interest* as the payments in the exchange represented two elements: principal and interest. The average imputed interest rate for the agreements was determined to be 8.6% as of March 31, 2026. The rate was determined primarily based on the rate the Company could obtain by financing from other sources at the date of the transaction.

Interest expense related to these agreements for the three months ended March 31, 2026 and 2025 was $164 thousand and $75 thousand, respectively. Interest expense related to these agreements for the six months ended March 31, 2026 and 2025 was $289 thousand and $150 thousand, respectively. These amounts are within "Interest expense" within the Condensed Consolidated Statements of Operations.

The amounts owed for these agreements are in Accounts payable and accrued expenses and Other noncurrent liabilities because they are owed to vendors rather than banks or financial institutions for borrowings. See *Note 9 Line of Credit* for amounts due to financial institutions for borrowings.

[**Table of Contents**](#TOC)

Below are details of the agreements with the vendors that contain imputed interest:

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **September 30, 2025** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** |
| Current | $5126 | $3475 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: discount | (512) | (315) |
| Total within Accounts payable and accrued expenses | $4614 | $3160 |
| Noncurrent | $4391 | $1786 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: discount | (236) | (114) |
| Total within Other noncurrent liabilities | $4155 | $1672 |

---

The TS segment has many vendors it transacts with and does not have any specific agreement with these vendors that it must purchase certain products from the vendor. Management believes other suppliers could provide similar products on comparable terms.

***9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Line of Credit***

As of March 31, 2026 and September 30, 2025, the Company maintained an inventory line of credit with a borrowing capacity of $15.0 million. It may be used by the TS and HPP segments in the U.S. to purchase inventory from approved vendors with payment terms which exceed those offered by the vendors. No interest accrues under the inventory line of credit when advances are paid within terms, however, late payments are subject to an interest charge of the rate published in the Wall Street Journal as the "prime rate" plus 1%, which was 7.75% as of March 31, 2026. The line of credit automatically renews for one year periods unless terminated by the Company with at least 60 days' notice or immediate termination by the lender. The collateral is a blanket UCC filing on Modcomp, Inc., a wholly-owned subsidiary, and CSPi assets. The credit agreement for the inventory line of credit contains financial covenants which require the Company to maintain the following TS segment-specific financial ratios: (1) a minimum current ratio of 1.2, (2) tangible net worth of no less than $4.0 million, and (3) a maximum ratio of total liabilities to total net worth of less than 5:1. As of March 31, 2026 and September 30, 2025, Company borrowings, all from the TS segment, under the inventory line of credit were $0.9 million and $0.9 million, respectively, and the Company was in compliance with all financial covenants. As of March 31, 2026 and September 30, 2025, this line of credit also included availability of a limited cash withdrawal of up to $1.0 million. As of March 31, 2026 and September 30, 2025 there were no cash withdrawals outstanding.

*10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pension and Retirement Plans*

The Company's operations have defined benefit and defined contribution plans in the U.K. and in the U.S. In the U.K., the Company provides defined benefit pension plans and defined contribution plans for some of its employees. In the U.S., the Company provides benefits through supplemental retirement plans to certain former employees. The U.S. supplemental retirement plans have life insurance policies which are not plan assets but were purchased by the Company as a vehicle to fund the costs of the plan. The Company also provides for officer death benefits through post-retirement plans to certain current officers of the Company in the U.S. All the Company's defined benefit plans are closed to newly hired employees and have been since September 2009.

The Company funds its pension plans in amounts sufficient to meet the requirements set forth in applicable employee benefits laws and local tax laws. Liabilities for amounts in excess of these funding levels are accrued and reported in the condensed consolidated balance sheets.

The Company's pension plan in the U.K. is the only pension plan with plan assets. In fiscal year 2025 the Company paid 8.5 million Great British Pounds to enter into a buy-in contract. This payment is subject to adjustment as a result of subsequent data cleansing activities. Under the terms of this buy-in contract, the insurer is liable to pay the benefits

[**Table of Contents**](#TOC)

of the plan, but the Company still retains full legal responsibility to pay the benefits to members using the insurance payments. The buy-in contract is treated as a plan asset. When the buy-in contract transitions to a buy-out contract the Company will be relieved of primary responsibility for the pension benefit obligation and settlement will be recognized.

The components of net periodic benefit costs related to the US and UK plans are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended March 31,**  | **Three Months Ended March 31,**  | **Three Months Ended March 31,**  | **Three Months Ended March 31,**  | **Three Months Ended March 31,**  | **Three Months Ended March 31,**  |
|  | **2026** | **2026** | **2026** | **2025** | **2025** | **2025** |
|  | **U.K.** | **U.S.** | **Total** | **U.K.** | **U.S.** | **Total** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** |
| **Pension:** |  |  |  |  |  |  |
| Interest cost | $114 | $2 | $116 | $104 | $2 | $106 |
| Expected return on plan assets | (114) |  | (114) | (122) |  | (122) |
| Amortization of past service costs | 2 |  | 2 | 2 |  | 2 |
| Amortization of net gain |  | (1) | (1) |  | (1) | (1) |
| Net periodic (benefit) cost | $2 | $1 | $3 | $(16) | $1 | $(15) |
| **Post Retirement:** |  |  |  |  |  |  |
| Service cost | $— | $6 | $6 | $— | $6 | $6 |
| Interest cost |  | 15 | 15 |  | 15 | 15 |
| Amortization of net gain |  | (32) | (32) |  | (30) | (30) |
| Net periodic benefit | $— | $(11) | $(11) | $— | $(9) | $(9) |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Six Months Ended March 31,**  | **Six Months Ended March 31,**  | **Six Months Ended March 31,**  | **Six Months Ended March 31,**  | **Six Months Ended March 31,**  | **Six Months Ended March 31,**  |
|  | **2026** | **2026** | **2026** | **2025** | **2025** | **2025** |
|  | **U.K.** | **U.S.** | **Total** | **U.K.** | **U.S.** | **Total** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** |
| **Pension:** |  |  |  |  |  |  |
| Interest cost | $227 | $4 | $231 | $209 | $4 | $213 |
| Expected return on plan assets | (227) |  | (227) | (244) |  | (244) |
| Amortization of past service costs | 4 |  | 4 | 4 |  | 4 |
| Amortization of net gain |  | (2) | (2) |  | (3) | (3) |
| Net periodic cost (benefit) | $4 | $2 | $6 | $(31) | $1 | $(30) |
| **Post Retirement:** |  |  |  |  |  |  |
| Service cost | $— | $12 | $12 | $— | $13 | $13 |
| Interest cost |  | 31 | 31 |  | 30 | 30 |
| Amortization of net gain |  | (64) | (64) |  | (60) | (60) |
| Net periodic benefit | $— | $(21) | $(21) | $— | $(17) | $(17) |

---

The fair value of the assets held by the UK pension plan by asset category are as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Fair Values as of** | **Fair Values as of** | **Fair Values as of** | **Fair Values as of** | **Fair Values as of** | **Fair Values as of** | **Fair Values as of** | **Fair Values as of** |
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Fair Value Measurements Using Inputs Considered as** | **Fair Value Measurements Using Inputs Considered as** | **Fair Value Measurements Using Inputs Considered as** | **Fair Value Measurements Using Inputs Considered as** | **Fair Value Measurements Using Inputs Considered as** | **Fair Value Measurements Using Inputs Considered as** | **Fair Value Measurements Using Inputs Considered as** | **Fair Value Measurements Using Inputs Considered as** |
| <br>**Asset Category** | **Total** | **Level 1** | **Level 2** | **Level 3** | **Total** | **Level 1** | **Level 2** | **Level 3** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** |
| Cash on deposit | $66 | $66 | $— | $— | $42 | $42 | $— | $— |
| Buy-in contract\* | 8281 |  |  | 8281 | 8428 |  |  | 8428 |
| Total plan assets | $8347 | $66 | $— | $8281 | $8470 | $42 | $— | $8428 |

---

\*This fair value is based on the latest information available, which is as of September 30, 2025 not March 31, 2026 as the table is labeled. The difference from September 30, 2025 is due to the Great British Pounds being converted into U.S. dollars at a different exchange rate.

[**Table of Contents**](#TOC)

***11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income Taxes***

The Company recorded an income tax benefit of $568 thousand and $683 thousand for the three months ended March 31, 2026 and 2025, respectively. An income tax benefit of $288 thousand and $798 thousand was recorded for the six months ended March 31, 2026 and 2025, respectively. For all of these periods, the difference between our effective income tax rate and the U.S. federal statutory rate was the impact of tax credits that we expect to be able to utilize against federal and state taxes, the change in valuation allowance maintained against certain state tax credits, and the excess tax benefits on restricted stock awards that vested during the period.

*12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated Other Comprehensive Loss*

The components of accumulated other comprehensive loss are as follows:

---

| | | |
|:---|:---|:---|
|  | **March 31,** <br>**2026** | **September 30,**<br>**2025** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** |
| Cumulative effect of foreign currency translation, net | $(4093) | $(4010) |
| Cumulative unrealized loss on pension liability | (3982) | (3982) |
| Accumulated other comprehensive loss, net | $(8075) | $(7992) |

---

*13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fair Value of Financial Assets and Liabilities*

Under the fair value standards, fair value is based on the exit price and defined as the price that would be received to sell an asset or transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement should reflect all the assumptions that market participants would use in pricing an asset or liability. A fair value hierarchy is established in the authoritative guidance outlined in three levels ranking from Level 1 to Level 3 with Level 1 being the highest priority.

Level 1: observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets

Level 2: inputs other than quoted prices included in Level 1 that are observable for the asset or liability either directly or indirectly

Level 3: unobservable inputs (e.g., a reporting entity's or other entity's own data)

The Company had no assets or liabilities measured at fair value on a recurring basis (except our pension plan assets and whole life insurance policies, see *Note 10 Pension and Retirement Plans* for pension plan assets) or non-recurring basis as of March 31, 2026 or September 30, 2025.

[**Table of Contents**](#TOC)

To estimate fair value of the financial instruments below, quoted market prices are used when available and classified within Level 1. If this data is not available, we use observable market-based inputs to estimate fair value, which are classified within Level 2. If the preceding information is unavailable, we use internally generated data to estimate fair value which is classified within Level 3.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **As of March 31, 2026** | **As of March 31, 2026** | **As of September 30, 2025** | **As of September 30, 2025** | | |
|  | **Carrying Amount** | **Fair Value** | **Carrying Amount** | **Fair Value** | <br>**Fair Value Level** | <br>**Reference** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** |  |  |
| **Assets:** |  |  |  |  |  |  |
| Cash and cash equivalents | $23101 | $23101 | $27418 | $27418 | 1 | Condensed Consolidated Balance Sheets |
| Accounts receivable, net | 13550 | 13550 | 12000 | 12000 | 1 | Condensed Consolidated Balance Sheets and Note 4 |
| Financing receivables, net\* | 16361 | 16361 | 14904 | 14904 | 3 | Condensed Consolidated Balance Sheets and Note 5 |
| **Liabilities:** |  |  |  |  |  |  |
| Accounts payable and accrued expenses and other noncurrent liabilities\*\* | 8769 | 8769 | 4832 | 4832 | 3 | Note 8 |
| Line of Credit | 867 | 867 | 903 | 903 | 2 | Condensed Consolidated Balance Sheets and Note 9 |

---

\*Original maturity over one year

\*\* Vendor financing agreements with original maturity over one year included within Accounts payable and accrued expenses and Other noncurrent liabilities

Cash and cash equivalents

Carrying amount approximated fair value.

Accounts receivable and Accounts payable and accrued expenses with original maturity of less than one year

Fair value was not materially different from their carrying values as of March 31, 2026, and September 30, 2025

Financing receivables, net

Fair value was estimated by discounting future cash flows based on the current rate with similar terms.

Vendor financing agreements within Accounts payable and accrued expenses and other noncurrent liabilities with original maturity over one year

Fair value was estimated by discounting future cash flows based on the current rate with similar terms.

Line of credit

The fair value of our line of credit is based on borrowing rates currently available to a market participant for loans with similar terms or maturity. The carrying amount of our outstanding revolving line of credit approximates fair value because the base interest rate charged varies with market conditions and the credit spread is commensurate with current market spreads for issuers of similar risk. No interest accrues under the inventory line of credit when advances are paid within terms.

[**Table of Contents**](#TOC)

*14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Segment Information*

We have two reporting segments, High Performance Products and Technology Solutions, discussed below. The Company's country of domicile is the United States.

*High Performance Products (HPP)* **–** The HPP segment consists of primarily of the following product lines: ARIA, Multicomputer, and Myricom. Most of the revenue is from US customers for all product lines, but the segment has expanded into APAC and Africa regions with its ARIA product line. The segment's operations are based in Lowell, Massachusetts.

*Technology Solutions (TS)* **–** The TS segment generates revenue by reselling third-party computer hardware, software, and related support/maintenance/warranty as a value-added reseller ("VAR"). The TS segment generates service revenues by the delivery of professional services for complex IT solutions, including advanced security; unified communications and collaboration; wireless and mobility; data center solutions; and network solutions as well as managed IT services that primarily serve the small and mid-sized business market. TS has two divisions – United Kingdom and U.S. which are displayed separately and in total below. The U.S. division, located in Boca Raton, Florida, primarily has U.S. customers and the United Kingdom division, located in Wokingham, Berkshire, primarily has U.K. customers as well as other European countries.

The factors used in identifying the Company's reportable segments include geographical location of operations and the types of products and services. The accounting policies of the Company's segments are consistent with those described in *Note 1 Basis of presentation and Summary of Significant Accounting Policies* of the company's Annual Report on Form 10-K for the fiscal year ended September 30, 2025. All intercompany revenues are eliminated in consolidation and are not reviewed when evaluating segment performance. The Company's Chief Operating Decision Maker ("CODM") Victor Dellovo, Chief Executive Officer, assesses segment performance and allocates resources based upon revenues and operating income before certain other nonroutine items, if any. Asset information utilized by the CODM for purposes of assessing performance and allocating resources includes Cash and cash equivalents, Accounts receivable, and Financing receivables. Cash and cash equivalents are utilized due to the HPP segment incurring losses and receiving cash from the TS-US division. Accounts and Financing receivables are regularly provided to the CODM to assess customer trends, credit policies, and operational efficiency. The following tables presents certain operating segment information.

[**Table of Contents**](#TOC)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Technology Solutions Segment** | **Technology Solutions Segment** | **Technology Solutions Segment** | |
| <br>**Three months ended March 31,** | <br>**High**<br>**Performance**<br>**Products**<br>**Segment** | <br>**United**<br>**Kingdom** | <br>**U.S.** | <br>**Total** | <br>**Consolidated**<br>**Total** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** |
| **2026** |  |  |  |  |  |
| Sales: |  |  |  |  |  |
| &nbsp;&nbsp;Product | $66 | $47 | $11000 | $11047 | $11113 |
| &nbsp;&nbsp;Service | 282 | 30 | 4587 | 4617 | 4899 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | 348 | 77 | 15587 | 15664 | 16012 |
| Cost of sales: |  |  |  |  |  |
| &nbsp;&nbsp;Product | 7 | 35 | 9356 | 9391 | 9398 |
| &nbsp;&nbsp;Services | 168 |  | 1974 | 1974 | 2142 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cost of sales | 175 | 35 | 11330 | 11365 | 11540 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 173 | 42 | 4257 | 4299 | 4472 |
| Research and development | 818 |  |  |  | 818 |
| Selling, general and administrative | 1043 | 112 | 3350 | 3462 | 4505 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 1861 | 112 | 3350 | 3462 | 5323 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating (loss) income | $(1688) | $(70) | $907 | $837 | $(851) |
| Interest expense | $(4) | $— | $(163) | $(163) | $(167) |
| Interest income | $— | $32 | $495 | $527 | $527 |
| Depreciation and amortization | $(17) | $— | $(51) | $(51) | $(68) |
| Cash and cash equivalents | $60 | $5012 | $18029 | $23041 | $23101 |
| Accounts receivable, net of allowance | $513 | $566 | $12471 | $13037 | $13550 |
| Financing receivables, net of allowance | $— | $— | $16361 | $16361 | $16361 |
| Total assets | $12017 | $5674 | $52626 | $58300 | $70317 |
| Capital expenditures | $(2) | $— | $(12) | $(12) | $(14) |
| **2025** |  |  |  |  |  |
| Sales: |  |  |  |  |  |
| &nbsp;&nbsp;Product | $273 | $417 | $7862 | $8279 | $8552 |
| &nbsp;&nbsp;Service | 374 | 62 | 4159 | 4221 | 4595 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | 647 | 479 | 12021 | 12500 | 13147 |
| Cost of sales: |  |  |  |  |  |
| &nbsp;&nbsp;Product | 101 | 385 | 6393 | 6778 | 6879 |
| &nbsp;&nbsp;Services | 175 | 23 | 1863 | 1886 | 2061 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cost of sales | 276 | 408 | 8256 | 8664 | 8940 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 371 | 71 | 3765 | 3836 | 4207 |
| Research and development | 763 |  |  |  | 763 |
| Selling, general and administrative | 1174 | 91 | 3173 | 3264 | 4438 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 1937 | 91 | 3173 | 3264 | 5201 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating (loss) income | $(1566) | $(20) | $592 | $572 | $(994) |
| Interest expense | $(3) | $— | $(74) | $(74) | $(77) |
| Interest income | $1 | $43 | $370 | $413 | $414 |
| Depreciation and amortization | $(18) | $— | $(41) | $(41) | $(59) |
| Cash and cash equivalents | $74 | $4571 | $24850 | $29421 | $29495 |
| Accounts receivable, net of allowance | $794 | $621 | $12230 | $12851 | $13645 |
| Financing receivables, net of allowance | $— | $— | $6391 | $6391 | $6391 |
| Total assets | $11544 | $8061 | $47517 | $55578 | $67122 |
| Capital expenditures | $(2) | $— | $(5) | $(5) | $(7) |

---

[**Table of Contents**](#TOC)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Technology Solutions Segment** | **Technology Solutions Segment** | **Technology Solutions Segment** | |
| <br>**Six months ended March 31,** | <br>**High**<br>**Performance**<br>**Products**<br>**Segment** | <br>**United**<br>**Kingdom** | <br>**U.S.** | <br>**Total** | <br>**Consolidated**<br>**Total** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** |
| **2026** |  |  |  |  |  |
| Sales: |  |  |  |  |  |
| &nbsp;&nbsp;Product | $273 | $69 | $17472 | $17541 | $17814 |
| &nbsp;&nbsp;Service | 928 | 41 | 9265 | 9306 | 10234 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | 1201 | 110 | 26737 | 26847 | 28048 |
| Cost of sales: |  |  |  |  |  |
| &nbsp;&nbsp;Product | 16 | 51 | 14613 | 14664 | 14680 |
| &nbsp;&nbsp;Services | 393 |  | 3768 | 3768 | 4161 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cost of sales | 409 | 51 | 18381 | 18432 | 18841 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 792 | 59 | 8356 | 8415 | 9207 |
| Research and development | 1676 |  |  |  | 1676 |
| Selling, general and administrative | 2077 | 200 | 6217 | 6417 | 8494 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 3753 | 200 | 6217 | 6417 | 10170 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating (loss) income | $(2961) | $(141) | $2139 | $1998 | $(963) |
| Interest expense | $(7) | $— | $(288) | $(288) | $(295) |
| Interest income | $1 | $68 | $1059 | $1127 | $1128 |
| Depreciation and amortization | $(36) | $— | $(94) | $(94) | $(130) |
| Cash and cash equivalents | $60 | $5012 | $18029 | $23041 | $23101 |
| Accounts receivable, net of allowance | $513 | $566 | $12471 | $13037 | $13550 |
| Financing receivables, net of allowance | $— | $— | $16361 | $16361 | $16361 |
| Total assets | $12017 | $5674 | $52626 | $58300 | $70317 |
| Capital expenditures | $(3) | $— | $(116) | $(116) | $(119) |
| **2025** |  |  |  |  |  |
| Sales: |  |  |  |  |  |
| &nbsp;&nbsp;Product | $355 | $550 | $18662 | $19212 | $19567 |
| &nbsp;&nbsp;Service | 722 | 109 | 8419 | 8528 | 9250 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total sales | 1077 | 659 | 27081 | 27740 | 28817 |
| Cost of sales: |  |  |  |  |  |
| &nbsp;&nbsp;Product | 123 | 504 | 15371 | 15875 | 15998 |
| &nbsp;&nbsp;Services | 368 | 49 | 3631 | 3680 | 4048 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cost of sales | 491 | 553 | 19002 | 19555 | 20046 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 586 | 106 | 8079 | 8185 | 8771 |
| Research and development | 1549 |  |  |  | 1549 |
| Selling, general and administrative | 2276 | 221 | 6073 | 6294 | 8570 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 3825 | 221 | 6073 | 6294 | 10119 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating (loss) income | $(3239) | $(115) | $2006 | $1891 | $(1348) |
| Interest expense | $(5) | $— | $(149) | $(149) | $(154) |
| Interest income | $2 | $92 | $809 | $901 | $903 |
| Depreciation and amortization | $(38) | $— | $(84) | $(84) | $(122) |
| Cash and cash equivalents | $74 | 4571 | 24850 | $29421 | $29495 |
| Accounts receivable, net of allowance | $794 | 621 | 12230 | $12851 | $13645 |
| Financing receivables, net of allowance | $— |  | 6391 | $6391 | $6391 |
| Total assets | $11544 | $8061 | $47517 | $55578 | $67122 |
| Capital expenditures | $(3) | $— | $(51) | $(51) | $(54) |

---

Depreciation and amortization are included in Selling, general, and administrative expenses. Operating (loss) income is not affected by either non-operating charges/income or by income taxes. Non-operating charges/income consists principally of foreign exchange gain (loss), interest income, and interest expense. Our long-lived assets are located in the United States.

[**Table of Contents**](#TOC)

#### Concentrations of Credit Risk
All customers below are in the U.S. division of our TS segment. Each customer's letter (e.g. "Customer A") does not change meaning if Customer A is in multiple tables, it is the same customer.

Below are customers with 10% or more of accounts receivable as of March 31, 2026 or September 30, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of March 31, 2026** | **As of March 31, 2026** | **As of September 30, 2025** | **As of September 30, 2025** |
|  | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** |
|  |  | **% of Total** |  | **% of Total** |
|  | **Accounts receivable** | **Accounts receivable** | **Accounts receivable** | **Accounts receivable** |
| Customer A | $1.6 | 12% | $0.3 | 3% |

---

Below are customers with 10% or more of financing receivables as of March 31, 2026 or September 30, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of March 31, 2026** | **As of March 31, 2026** | **As of September 30, 2025** | **As of September 30, 2025** |
|  | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** |
|  |  | **% of Total** |  | **% of Total** |
|  | **Financing Receivables** | **Financing Receivables** | **Financing Receivables** | **Financing Receivables** |
| Customer B | $2.6 | 16% | $0.8 | 5% |
| Customer A | $2.8 | 17% | $5.9 | 40% |
| Customer C | $2.1 | 13% | $0.2 | 1% |
| Customer D | $2.0 | 12% | $2.8 | 19% |
| Customer E | $1.5 | 9% | $1.6 | 11% |

---

The following table lists customers from which the Company derived revenues of 10% or more of total revenues for the three and six months ended March 31, 2026 and 2025.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** | **Six months ended March 31,** | **Six months ended March 31,** | **Six months ended March 31,** | **Six months ended March 31,** |
|  | **2026** | **2026** | **2025** | **2025** | **2026** | **2026** | **2025** | **2025** |
|  | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** |
|  | **Customer** | **% of Total** | **Customer** | **% of Total** | **Customer** | **% of Total** | **Customer** | **% of Total** |
|  | **Revenues** | **Revenues** | **Revenues** | **Revenues** | **Revenues** | **Revenues** | **Revenues** | **Revenues** |
|  | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** | **(Amounts in millions)** |
| Customer F | $2.8 | 18% | $— | -% | $3.1 | 11% | $— | -% |
| Customer G | $0.6 | 4% | $1.5 | 11% | $1.0 | 4% | $2.6 | 9% |

---

***15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend***

On December 16, 2025, the Company's board of directors declared a dividend of $0.03 per share payable January 15, 2026, to shareholders of record on the close of business on December 26, 2025.

On February 12, 2026, the Company's board of directors declared a dividend of $0.03 per share payable March 12, 2026, to shareholders of record on the close of business on February 26, 2026.

[**Table of Contents**](#TOC)

#### Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

#### Forward-Looking Statements
The discussion below contains certain forward-looking statements including, but not limited to, among others, statements concerning future revenues and future business plans. Forward-looking statements include statements in which we use words such as "expect", "believe", "anticipate", "intend", "project", "estimate", "should", "could", "may", "plan", "potential", "predict", "will", "would" and similar expressions. Although we believe the expectations reflected in such forward-looking statements are based on reasonable assumptions, the forward-looking statements are subject to significant risks and uncertainties, and thus we cannot assure you that these expectations will prove to have been correct, and actual results may vary from those contained in such forward-looking statements. We discuss many of these risks and uncertainties in Item 1A under the heading "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025. Factors that may cause such variances include, but are not limited to, our dependence on a small number of customers for a significant portion of our revenue, intense competition in the market segments in which we operate, changes in the U.S. Tax laws, the impact of the Ukrainian-Russian military and Israeli-Hamas conflict on global trade and financial markets, the impact of tariffs or trade policies, and the impact of pandemics on our business, results of operations and financial condition. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our estimates and assumptions only as of the date of this document. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statements contained in this report, whether as a result of new information, future events or otherwise. This management's discussion and analysis of financial condition and results of operations should be read in conjunction with our financial statements and the related notes included elsewhere in this filing and in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025.

#### Critical Accounting Policies
Our discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis, we evaluate our estimates, including those related to the allowance for credit losses for accounts receivable and financing receivables, inventory valuation, impairment assessment of intangibles, income taxes, deferred compensation and retirement plans, as well as estimated selling prices used for revenue recognition and contingencies. We base our estimates on historical performance and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. A description of our critical accounting policies is contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025 in the "Critical Accounting Policies" section contained in Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations. Management believes there have been no significant changes for the six months ended March 31, 2026 to the items that we disclosed as our critical accounting estimates in the Management's Discussion and Analysis of Financial Condition and Results of Operations section of our Annual Report on Form 10-K for the fiscal year ended September 30, 2025.

#### Results of Operations

#### Overview of the three months ended March 31, 2026
Our sales increased by $2.9 million, or 22%, to $16.0 million for the three months ended March 31, 2026 compared to $13.1 million for the three months ended March 31, 2025. Our gross margin percentage decreased to 28% for the three months ended March 31, 2026 compared to 32% for the same prior year period. For the three months ended March 31, 2026 there was an operating loss of $0.9 million compared to an operating loss of $1.0 million for the three months ended March 31, 2025. Other income, net increased $0.3 million to $0.5 million for the three months ended March 31, 2026 compared to $0.2 million for the same prior year period. An income tax benefit of $0.6 million was recorded for

[**Table of Contents**](#TOC)

the three months ended March 31, 2026 compared to an income tax benefit of $0.7 million in the same period in the prior year.

The following table details our results of operations in dollars and as a percentage of sales for the three months ended March 31, 2026 and 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | <br>**March 31, 2026** | **%**<br>**of sales** | <br>**March 31, 2025** | **%**<br>**of sales** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| Sales | $16012 | 100% | $13147 | 100% |
| Costs and expenses: |  |  |  |  |
| &nbsp;&nbsp;Cost of sales | 11540 | 72% | 8940 | 68% |
| &nbsp;&nbsp;Research and development | 818 | 5% | 763 | 6% |
| &nbsp;&nbsp;Selling, general and administrative | 4505 | 28% | 4438 | 34% |
| Total costs and expenses | 16863 | 105% | 14141 | 108% |
| Operating loss | (851) | (5)% | (994) | (8)% |
| Other income, net | 547 | 3% | 203 | 2% |
| Loss before income taxes | (304) | (2)% | (791) | (6)% |
| Income tax benefit | (568) | (4)% | (683) | (5)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | $264 | 2% | $(108) | (1)% |

---

#### Sales
TS segment sales change was as follows for the three months ended March 31, 2026 and 2025:

---

| | | | |
|:---|:---|:---|:---|
|  | **March 31,**  | **March 31,**  | **Increase** |
|  | **2026** | **2025** | $**%** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| Products | $11047 | $8279 | 33% |
| Services | 4617 | 4221 | 9% |
| Total | $15664 | $12500 | 25% |

---

The increase in TS segment product sales of $2.8 million is primarily due to increased sales to several existing major customers in the US division of $3.2 million, partially offset with decreased sales to two existing customers in the UK division of $0.4 million. Service sales for the three months ended March 31, 2026 increased $0.4 million from the same prior year period, which was attributable to the US division. The increase consisted of an increase in third-party maintenance sales of $0.3 million and an increase in managed services of $0.2 million, partially offset by a $0.1 million decrease from internal and third-party services.

HPP segment sales change was as follows for the three months ended March 31, 2026 and 2025:

---

| | | | |
|:---|:---|:---|:---|
|  | **March 31,**  | **March 31,**  | **Decrease** |
|  | **2026** | **2025** | $**%** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| Products | $66 | $273 | (76)% |
| Services | 282 | 374 | (25)% |
| Total | $348 | $647 | (46)% |

---

The HPP product sales decreased $0.2 million for the three months ended March 31, 2026 compared to the same prior year period primarily due to decreased ARIA AZT revenue. The HPP service sales decreased $0.1 million due to one nonrecurring customer support sale.

[**Table of Contents**](#TOC)

Our sales by geographic area, which are based on the customer location to which the products were shipped or services rendered, were as follows for the three months ended March 31, 2026 and 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **March 31,**  | **March 31,**  | **March 31,**  | **March 31,**  | **Increase (decrease)** |
|  | **2026** | **%** | **2025** | **%** | $**%** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| Americas | $15936 | 100% | $12343 | 94% | 29% |
| Europe | 58 | —% | 655 | 5% | (91)% |
| APAC and Africa | 18 | —% | 149 | 1% | (88)% |
| &nbsp;&nbsp;Totals | $16012 | 100% | $13147 | 100% | 22% |

---

The $3.6 million increase in sales to the Americas was primarily the result of an increase in the TS-US division of $3.8 million, partially offset by a decrease of $0.2 million in the HPP segment. The $0.6 million decrease in sales to Europe was primarily the result of decreased sales by our TS-UK division of 0.4 million combined with a decrease in our TS-US division of $0.2 million. The sales to APAC and Africa decreased $0.1 million for the three months ended March 31, 2026 compared to the same prior year period due to the HPP segment.

#### Gross Margins
Our gross margin ("GM") increased $0.3 million for the three months ended March 31, 2026 as compared to the same prior year period. The GM as a percentage of sales decreased to 28% for the three months ended March 31, 2026 compared to the same prior year period of 32%.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **March 31,**  | **March 31,**  | **March 31,**  | **March 31,**  |  |  |
|  | **2026** | **2026** | **2025** | **2025** | **Increase (decrease)** | **Increase (decrease)** |
|  | **GM$** | **GM%** | **GM$** | **GM%** | **GM$** | **GM%** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| TS | $4299 | 27% | $3836 | 31% | $463 | (4)% |
| HPP | 173 | 50% | 371 | 57% | (198) | (7)% |
| Total | $4472 | 28% | $4207 | 32% | $265 | (4)% |

---

The impact of product mix within our TS segment on gross margin for the three months ended March 31, 2026 and 2025 was as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **March 31,**  | **March 31,**  | **March 31,**  | **March 31,**  |  |  |
|  | **2026** | **2026** | **2025** | **2025** | **Increase (decrease)** | **Increase (decrease)** |
|  | **GM$** | **GM%** | **GM$** | **GM%** | **GM$** | **GM%** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| Products | $1655 | 15% | $1500 | 18% | $155 | (3)% |
| Services | 2644 | 57% | 2336 | 55% | 308 | 2% |
| Total | $4299 | 27% | $3836 | 31% | $463 | (4)% |

---

The overall TS segment GM as a percentage of sales decreased to 27% for the three month period ended March 31, 2026 compared to 31% for the same prior year period. Product GM as a percentage of revenue decreased 3% due to a higher volume of sales with lower margins compared to the same prior year period. The service GM as a percentage of revenue increased 2% from the prior year primarily due to increased third-party maintenance sales, which are recorded "net" which means that the revenue, net of the associated cost, is recorded in the Services revenue financial statement line item causing an increase in GM as a percentage of sales.

[**Table of Contents**](#TOC)

The impact of product mix within our HPP segment on gross margin for the three months ended March 31, 2026 and 2025 was as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **March 31,**  | **March 31,**  | **March 31,**  | **March 31,**  |  |  |
|  | **2026** | **2026** | **2025** | **2025** | **Increase (decrease)** | **Increase (decrease)** |
|  | **GM$** | **GM%** | **GM$** | **GM%** | **GM$** | **GM%** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| Products | $60 | 91% | $173 | 63% | $(113) | 28% |
| Services | 113 | 40% | 198 | 53% | (85) | (13)% |
| Total | $173 | 50% | $371 | 57% | $(198) | (7)% |

---

The overall HPP segment GM as a percentage of sales decreased to 50% for the three months ended March 31, 2026 from 57% for the three months ended March 31, 2025. The 28% increase in product GM as a percentage of product revenue for the three months ended March 31, 2026 compared to the same prior year period was primarily attributed to the current period's product mix primarily consisting of software sales, which were nearly all GM. The service GM as a percentage of services revenue from the same prior year period decreased 13% to 40% for the three months ended March 31, 2026 compared to 53% for the three months ended March 31, 2025 due to one high GM customer support contract which did not recur in the current period.

#### Research and Development Expenses
The research and development expenses incurred by our HPP segment remained relatively flat at $0.8 million for three months ended March 31, 2026 compared to the same prior year period without any significant change in specific types of expenses. The current period expenses were primarily for product engineering expenses incurred in connection with the continued development of the ARIA Zero Trust Gateway cyber security products.

#### Selling, General and Administrative Expenses
The following table details our selling, general and administrative ("SG&A") expense by operating segment for the three months ended March 31, 2026 and 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** | |
|  | **2026** | **% of**<br>**Total** | **2025** | **% of**<br>**Total** | $%<br>**Increase**<br>**(Decrease)** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| **By Operating Segment:** |  |  |  |  |  |
| TS segment | $3462 | 77% | $3264 | 74% | 6% |
| HPP segment | 1043 | 23% | 1174 | 26% | (11)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $4505 | 100% | $4438 | 100% | 2% |

---

SG&A expenses increased $0.1 million to $4.5 million for the three months ended March 31, 2026 compared to the same prior year period of $4.4 million. The $0.2 million increase in TS segment SG&A expenses compared to the same prior year period is primarily the result of increased variable compensation. The HPP segment SG&A expenses decreased $0.1 million for the three months ended March 31, 2026 as compared to the prior year period primarily due to decreased consulting expenses.

[**Table of Contents**](#TOC)

#### Other Income/Expenses
The following table details other income, net for the three months ended March 31, 2026 and 2025:

---

| | | | |
|:---|:---|:---|:---|
|  | **Three months ended**  | **Three months ended**  | |
|  | **March 31, 2026** | **March 31, 2025** | <br>**$ Change** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** |
| Foreign exchange gain (loss) | $70 | $(132) | $202 |
| Interest expense | (167) | (77) | (90) |
| Interest income | 527 | 414 | 113 |
| Other income (expense), net | 117 | (2) | 119 |
| &nbsp;&nbsp;Total other income, net | $547 | $203 | $344 |

---

Total other income (expense), net for the three months ended March 31, 2026 increased $0.3 million to $0.5 million compared to $0.2 million for the same prior year period.

The $0.2 million increased foreign exchange gain (loss) for the three months ended March 31, 2026 was primarily due to the US Dollar strengthening in the current period compared to the same prior year period in which it weakened relative to the British Pound. In consolidation, US dollars are remeasured into the functional currency, British Pounds, of our UK subsidiary. This non-cash remeasurement is included in the Foreign exchange gain (loss) in the Consolidated Statements of Operations. The foreign exchange gain (loss) was primarily from the US Dollar balance in our TS UK division.

Interest income increased $113 thousand for the three months ended March 31, 2026 compared to the same prior year period primarily due to increased interest income from agreements that have payment terms in excess of one year (see *Note 5 Financing receivables, net* in Item 1 to this Quarterly Report on Form 10-Q for details), partially offset by a reduction in interest rates related to our Cash and cash equivalents combined with a decreased average balance. All of these agreements are in the TS-US division.

The interest expense increase of $90 thousand for the three months ended March 31, 2026 compared to the same prior year period was related to the TS US division entering into additional multi-year vendor contracts related to sales agreements that have payment terms in excess of one year. Not all sales agreements that have payments in excess of one year have related multi-year vendor contracts.

#### Income Taxes
The Company recorded an income tax benefit of $568 thousand and $683 thousand for the three months ended March 31, 2026 and 2025, respectively. For these periods, the difference between our effective income tax rate and the U.S. federal statutory rate was the impact of tax credits that we expect to be able to utilize against federal and state taxes, the change in valuation allowance maintained against certain state tax credits, and the excess tax benefits on restricted stock awards that vested during the period.

#### Overview of the six months ended March 31, 2026
Our sales decreased by approximately $0.8 million, or 3%, to $28.0 million for the six months ended March 31, 2026 as compared to $28.8 million for the six months ended March 31, 2025. The decrease in sales is the result of a decrease of $0.9 million in the TS segment, partially offset by an increase of $0.1 million in our HPP segment. Our gross margin percentage increased 3% to 33% of sales for the six months ended March 31, 2026 compared to 30% for the six months ended March 31, 2025. For the six months ended March 31, 2026 operating loss was $1.0 million compared to operating loss of $1.3 million for the same prior year period. Other income, net increased $0.1 million for the six months

[**Table of Contents**](#TOC)

ended March 31, 2026 compared to same prior year period. An income tax benefit of $0.3 million was recorded for the six months ended March 31, 2026 compared to an income tax benefit of $0.8 million in the same prior year period.

The following table details our results of operations in dollars and as a percentage of sales for the six months ended March 31, 2026 and 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | <br>**March 31, 2026** | **%**<br>**of sales** | <br>**March 31, 2025** | **%**<br>**of sales** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| Sales | $28048 | 100% | $28817 | 100% |
| Costs and expenses: |  |  |  |  |
| &nbsp;&nbsp;Cost of sales | 18841 | 67% | 20046 | 70% |
| &nbsp;&nbsp;Research and development | 1676 | 6% | 1549 | 5% |
| &nbsp;&nbsp;Selling, general and administrative | 8494 | 30% | 8570 | 30% |
| Total costs and expenses | 29011 | 103% | 30165 | 105% |
| Operating loss | (963) | (3)% | (1348) | (5)% |
| Other income, net | 1030 | 3% | 914 | 3% |
| Income (loss) before income taxes | 67 | —% | (434) | (2)% |
| Income tax benefit | (288) | (1)% | (798) | (3)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $355 | 1% | $364 | 1% |

---

#### Sales
TS segment sales change was as follows for the six months ended March 31, 2026 and 2025:

---

| | | | |
|:---|:---|:---|:---|
|  | **March 31,**  | **March 31,**  | **Increase (decrease)** |
|  | **2026** | **2025** | $**%** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| Products | $17541 | $19212 | (9)% |
| Services | 9306 | 8528 | 9% |
| Total | $26847 | $27740 | (3)% |

---

The decrease in TS segment product sales of $1.7 million during the period as compared to the prior year period is primarily attributable to decreased sales of $1.2 million in the US division to existing major customers combined with a decrease in sales of $0.5 million in the UK division to three existing major customers. Service sales for the six months ended March 31, 2026 increased $0.8 million from the prior year period. In the U.S. division there was a $0.9 million increase due to an increase in third-party maintenance sales of $0.8 million and an increase in managed services of $0.4 million, partially offset by a decrease from internal and third-party services of $0.3 million. There was a $0.1 million decrease in the UK service sales due to a decrease in maintenance sales.

HPP segment sales change was as follows for the six months ended March 31, 2026 and 2025:

---

| | | | |
|:---|:---|:---|:---|
|  | **March 31,**  | **March 31,**  | **Increase (decrease)** |
|  | **2026** | **2025** | $**%** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| Products | $273 | $355 | (23)% |
| Services | 928 | 722 | 29% |
| Total | $1201 | $1077 | 12% |

---

HPP product sales decreased by $0.1 million for the six months ended March 31, 2026 as compared to the prior year period primarily as a result of one ARIA AZT order which occurred in the prior year period and did not recur in the current year. The HPP service sales increased $0.2 million for the six months ended March 31, 2026 compared to the prior year period due to increased revenue from Multicomputer repair services of $0.3 million, partially offset with decreased customer support revenue of $0.1 million.

[**Table of Contents**](#TOC)

Our sales by geographic area, which are based on the customer location to which the products were shipped or services rendered, were as follows for the six months ended March 31, 2026 and 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **March 31,**  | **March 31,**  | **March 31,**  | **March 31,**  | **Increase (decrease)** |
|  | **2026** | **%** | **2025** | **%** | $**%** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| Americas | $27454 | 98% | $27827 | 96% | (1)% |
| Europe | 128 | —% | 836 | 3% | (85)% |
| APAC and Africa | 466 | 2% | 154 | 1% | 203% |
| &nbsp;&nbsp;Totals | $28048 | 100% | $28817 | 100% | (3)% |

---

The $0.4 million decrease in sales to the Americas was the result of a decrease in the HPP segment of $0.2 million, a decrease of $0.1 million in the TS-US division, and a decrease in the TS-UK division of $0.1 million. The sales to Europe decreased $0.7 million from the prior year due to a decrease of $0.5 million in the TS-UK division combined with a decrease in the TS-US division of $0.2 million. The sales to APAC and Africa increased $0.3 million due to the HPP segment.

#### Gross Margins
Our gross margin ("GM") increased $0.4 million for the six months ended March 31, 2026 compared to the same prior year period. The GM as a percentage of total sales increased to 33% for the six months ended March 31, 2026 as compared to the same prior year period of 30%.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **March 31,**  | **March 31,**  | **March 31,**  | **March 31,**  |  |  |
|  | **2026** | **2026** | **2025** | **2025** | **Increase** | **Increase** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
|  | **GM$** | **GM%** | **GM$** | **GM%** | **GM$** | **GM%** |
| TS | $8415 | 31% | $8185 | 30% | $230 | 1% |
| HPP | 792 | 66% | 586 | 54% | 206 | 12% |
| Total | $9207 | 33% | $8771 | 30% | $436 | 3% |

---

The impact of product mix within our TS segment on gross margin for the six months ended March 31, 2026 and 2025 was as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **March 31,**  | **March 31,**  | **March 31,**  | **March 31,**  |  |  |
|  | **2026** | **2026** | **2025** | **2025** | **Increase (decrease)** | **Increase (decrease)** |
|  | **GM$** | **GM%** | **GM$** | **GM%** | **GM$** | **GM%** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| Products | $2877 | 16% | $3336 | 17% | $(459) | (1)% |
| Services | 5538 | 60% | 4849 | 57% | 689 | 3% |
| Total | $8415 | 31% | $8185 | 30% | $230 | 1% |

---

The overall TS segment GM as a percentage of total sales increased to 31% for the six month period ended March 31, 2026 compared to 30% from the same prior year period. Product GM as a percentage of revenue for the six months ended March 31, 2026 decreased 1% from the prior year period due to product mix. Service GM as a percentage of total sales increased to 60% for the six months ended March 31, 2026 compared to 57% from the prior year period. This was primarily due to increased third-party maintenance sales, which are recorded "net" which means that the revenue, net of the associated cost, is recorded in the Services revenue financial statement line item causing an increase in GM as a percentage of sales.

[**Table of Contents**](#TOC)

The impact of product mix within our HPP segment on gross margin for the six months ended March 31, 2026 and 2025 was as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **March 31,**  | **March 31,**  | **March 31,**  | **March 31,**  |  |  |
|  | **2026** | **2026** | **2025** | **2025** | **Increase** | **Increase** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
|  | **GM$** | **GM%** | **GM$** | **GM%** | **GM$** | **GM%** |
| Products | $257 | 94% | $233 | 66% | $24 | 28% |
| Services | 535 | 58% | 353 | 49% | 182 | 9% |
| Total | $792 | 66% | $586 | 54% | $206 | 12% |

---

The overall HPP segment GM as a percentage of sales increased to 66% for the six months ended March 31, 2026 from 54% for the six months ended March 31, 2025. The 28% increase in product GM as a percentage of product revenue compared to the same prior year period was primarily attributed to the product mix primarily consisting of software sales, which were nearly all GM. The 9% increase in service GM as a percentage of service revenue for the six months ended March 31, 2026 compared to the same prior year period was due to increased Multicomputer repair services, which are relatively high margin compared to other services.

#### Research and Development Expenses
The research and development expenses incurred by our HPP segment increased to $1.7 million for the six months ended March 31, 2026 compared to the same prior year period of $1.5 million due to increased salaries. The current period expenses were primarily for product engineering expenses incurred in connection with the continued development of the ARIA Zero Trust Gateway cyber security products.

#### Selling, General and Administrative Expenses
The following table details our selling, general and administrative ("SG&A") expense by operating segment for the six months ended March 31, 2026 and 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Six months ended March 31,** | **Six months ended March 31,** | **Six months ended March 31,** | **Six months ended March 31,** | |
|  | **2026** | **% of**<br>**Total** | **2025** | **% of**<br>**Total** | $%<br>**Increase**<br>**(Decrease)** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| **By Operating Segment:** |  |  |  |  |  |
| TS segment | $6417 | 76% | $6294 | 73% | 2% |
| HPP segment | 2077 | 24% | 2276 | 27% | (9)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $8494 | 100% | $8570 | 100% | (1)% |

---

SG&A expenses decreased $0.1 million for the six months ended March 31, 2026 compared to the same prior year period. The $0.1 million increase in TS segment SG&A expenses compared to the same prior year period is primarily the result of increased salaries and variable compensation. The HPP segment SG&A expenses decreased $0.2 million for the six months ended March 31, 2026 as compared to the same prior year period primarily due to decreased stock compensation expense and consulting expenses.

[**Table of Contents**](#TOC)

#### Other Income/Expenses
The following table details other income, net for the six months ended March 31, 2026 and 2025:

---

| | | | |
|:---|:---|:---|:---|
|  | **Six months ended**  | **Six months ended**  | |
|  | **March 31, 2026** | **March 31, 2025** | <br>**$ Change** |
|  | **(Amounts in thousands)** | **(Amounts in thousands)** | **(Amounts in thousands)** |
| Foreign exchange gain | $63 | $163 | $(100) |
| Interest expense | (295) | (154) | (141) |
| Interest income | 1128 | 903 | 225 |
| Other income, net | 134 | 2 | 132 |
| &nbsp;&nbsp;Total other income, net | $1030 | $914 | $116 |

---

Total other income, net for the six months ended March 31, 2026 increased $0.1 million to income of $1.0 million compared to income of $0.9 million in the same prior year period.

The $0.1 million decreased foreign exchange gain for the six months ended March 31, 2026 was due to the US Dollar strengthening less relative to the British Pound compared to the same prior year period. In consolidation, US dollars are remeasured into the functional currency, British Pounds, of our UK subsidiary. This non-cash remeasurement is included in the Foreign exchange gain in the Consolidated Statements of Operations. The foreign exchange gain in the current period was primarily from the US Dollar balance in our TS UK division.

Interest income increased $225 thousand for the six months ended March 31, 2026 compared to the same prior year period primarily due to increased interest income from agreements that have payment terms in excess of one year (see *Note 5 Financing receivables, net* in Item 1 to this Quarterly Report on Form 10-Q for details), partially offset with decreased interest rates related to our Cash and cash equivalents and a decreased average balance. All of these agreements are in the TS-US division.

The interest expense increase of $141 thousand for the six months ended March 31, 2026 compared to the same prior year period was primarily related to the TS US division entering into additional multi-year vendor contracts related to sales agreements in fiscal year 2026 and 2025 that have payment terms in excess of one year. Not all sales agreements that have payments in excess of one year have related multi-year vendor contracts.

#### Income Taxes
The Company recorded an income tax benefit of $288 thousand and $798 thousand for the six months ended March 31, 2026 and 2025, respectively. For these periods, the difference between our effective income tax rate and the U.S. federal statutory rate was the impact of tax credits that we expect to be able to utilize against federal and state taxes, the change in valuation allowance maintained against certain state tax credits, and the excess tax benefits on restricted stock awards that vested during the period.

#### Liquidity and Capital Resources
Our primary source of liquidity is our Cash and cash equivalents and our line of credit.

Cash and cash equivalents decreased by $4.3 million to $23.1 million as of March 31, 2026 from $27.4 million as of September 30, 2025.

[**Table of Contents**](#TOC)

The following is a summary of our cash flows for the six months ended March 31, 2026 and 2025:

---

| | | |
|:---|:---|:---|
|  | **Six months ended March 31,** | **Six months ended March 31,** |
|  | **2026** | **2025** |
|  | **(Dollar amounts in thousands)** | **(Dollar amounts in thousands)** |
| Net cash (used in) provided by: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating activities | $(3409) | $3653 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investing activities | (173) | (108) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financing activities | (695) | (4603) |
| Effect of exchange rate changes on cash | (40) | (32) |
| &nbsp;&nbsp;&nbsp;&nbsp;Decrease in Cash and cash equivalents | $(4317) | $(1090) |

---

*Operating Activities*

Cash used in operating activities was $3.4 million for the six months ended March 31, 2026 compared to $3.7 million provided by operating activities in the prior year. Our largest source of cash provided by our operations is receipts from our customers. Net cash provided by operating activities can be impacted by factors such as timing of when we invoice the customer and receive payment, when we receive vendor invoices and make payments as well as vendor payment terms, and inventory fluctuations are dependent on when orders are received and shipped.

The operating cash used during the period primarily reflects the payment of Accounts payable and accrued expenses outstanding as of September 30, 2025 and continued investment in ARIA Zero Trust Gateway cyber security products. Collections remained strong during the period.

*Investing Activities*

Cash used in investing activities increased $0.1 million for the six months ended March 31, 2026 compared to the same prior year period due to increased purchases of property, equipment, and improvements.

*Financing Activities*

Cash used in financing activities was $0.7 million for the six months ended March 31, 2026 compared to $4.6 million used in the same prior year period. The decrease from the prior year was primarily due to decreased net repayments on our line-of-credit of approximately $3.7 million from the prior year and repurchases of common stock of $0.2 million. The line-of-credit payment changes are due to the timing of sales and related vendor invoices.

***Other Liquidity and Capital Resources Items***

Our cash held by our foreign subsidiary in the United Kingdom totaled approximately $5.0 million as of March 31, 2026 and consisted of 0.9 million Euros, 0.2 million British Pounds, and 3.8 million US Dollars. This cash is included in our total Cash and cash equivalents reported on the Condensed Consolidated Balance Sheets.

As of March 31, 2026 and September 30, 2025, the Company maintained a line of credit with a capacity of up to $15.0 million for inventory accessible to both the HPP and TS segments. This line of credit also includes availability of a limited cash withdrawal of up to $1.0 million. As of March 31, 2026 and September 30, 2025 an amount of $14.1 million was available under the inventory line of credit. As of March 31, 2026 and September 30, 2025 there were no cash withdrawals outstanding. For further discussion of the Company's line of credit, including its financial covenants, see Item 1, *Note 9 Line of Credit.*

In the TS U.S. division, financing of goods and services is offered to certain customers. This involves amounts due reflecting sales whose payment terms exceed one year. As of March 31, 2026 and September 30, 2025 there were

[**Table of Contents**](#TOC)

$16.4 million and $14.9 million of Financing receivables, net outstanding, respectively. Of these amounts, $7.7 million and $8.9 million were current assets as of March 31, 2026 and September 30, 2025, respectively.

Related to the Financing Receivables, net there was a balance of $8.8 million and $4.8 million of multi-year contracts with financing due to our vendors. Of these amounts $4.6 million and $3.1 million were current liabilities as of March 31, 2026 and September 30, 2025, respectively. The current portion of these vendor financing arrangements is within Accounts payable and accrued expenses. The noncurrent portion is within Other noncurrent liabilities. Not every financing arrangement with our customers has a related vendor financing arrangement. Some vendors do not offer financing for agreements and if offered, management determines whether to use vendor financing due to various factors including interest rates and cash flow projections. Refer to *Note 5 – Financing receivables, net* and *Note 8 Accounts payable and accrued expenses, and Other noncurrent liabilities* for more information.

If cash generated from operations is insufficient to satisfy working capital requirements, we may need to access funds through bank loans or other means. If we are unable to secure additional financing, we may not be able to complete development or enhancement of products, take advantage of future opportunities, respond to competition, retain key employees, or continue to effectively operate our business.

Based on our current plans and business conditions, management believes that the Company's available Cash and cash equivalents, the cash generated from operations, and availability on our line of credit will be sufficient to provide for the Company's working capital and capital expenditure requirements for at least 12 months from the date of this filing.

#### Item 4. &nbsp;&nbsp;&nbsp;&nbsp; Controls and Procedures

#### Evaluation of Disclosure Controls and Procedures
The Company evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2026. Our Chief Executive Officer, our Chief Financial Officer and other members of our senior management team supervised and participated in this evaluation. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of March 31, 2026, the Company's Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective.

#### Changes in Internal Control over Financial Reporting
During the three months ended March 31, 2026, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

[**Table of Contents**](#TOC)

#### PART II. OTHER INFORMATION

#### Item 1A. &nbsp;&nbsp;&nbsp;&nbsp; Risk factors
**There have been no material changes to the risk factors set forth in Item 1A under the heading "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025.**

#### Item 2. &nbsp;&nbsp;&nbsp;&nbsp; Unregistered Sales of Equity Securities and Use of Proceeds
On February 8, 2011, the Board of Directors authorized the Company to repurchase up to 500 thousand shares of the Company's outstanding common stock at market price. The plan does not expire. The stock repurchase program may be suspended, terminated, or modified at any time for any reason.

Common stock of CSP Inc. may be repurchased on the open market at the discretion of management. Open market repurchases are made in compliance with the Securities and Exchanges Commission's Rule 10b-18 in addition to complying with applicable legal and other considerations. Below are the purchases that have been made for the three months ended March 31, 2026.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total number of shares purchased** | **Average price paid per share** | **Total number of shares purchased as part of publicly announced plans** | **Maximum number of shares that may yet be purchased under the plans** |
| January 1-31, 2026 |  |  |  | 272354 |
| February 1-28, 2026 | 7310 | $9.24 | 7310 | 265044 |
| March 1-31, 2026 | 8200 | 8.78 | 8200 | 256844 |
| Total | 15510 | $9.00 | 15510 |  |

---

**Item 5. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Information**

During the three months ended March 31, 2026, no director or officer of the Company adopted, modified, or terminated any "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

[**Table of Contents**](#TOC)

#### Item 6. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits

---

| | |
|:---|:---|
| **Number** | **Description** |
| 10.2\* | [Offer Letter of Employment, Agreed and Accepted the 7th day of January 2026 between CSP Inc. and Eric Sachs](cspi-20260331xex10d2.htm)<br>|
| 31.1\* | [Rule 13(a)-14(a) / 15d-14(a) Certification of Chief Executive Officer](cspi-20260331xex31d1.htm) |
| 31.2\* | [Rule 13(a)-14(a) / 15d-14(a) Certification of Chief Financial Officer](cspi-20260331xex31d2.htm) |
| 32.1\* | [Section 1350 Certifications of Chief Executive Officer and Chief Financial Officer](cspi-20260331xex32d1.htm) |
| 101\* | The following financial statements for the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 formatted in eXtensible Business Reporting Language (XBRL) (a) our Condensed Consolidated Balance Sheets as of March 31, 2026 and September 30, 2025, (b) our Condensed Consolidated Statements of Operations for the three and six months ended March 31, 2026 and 2025, (c) our Condensed Consolidated Statements of Comprehensive Income for the three and six months ended March 31, 2026 and 2025, (d) our Condensed Consolidated Statement of Shareholders' Equity for the three and six months ended March 31, 2026 and 2025, (e) our Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2026 and 2025 and (f) the Notes to such Condensed Consolidated Financial Statements.<br>|
| 104\* | The cover page from this Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, formatted in inline XBRL. |

---

\* Filed Herewith

[**Table of Contents**](#TOC)

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | CSP INC. | CSP INC. |
| May 7, 2026 | By: | /s/ Victor Dellovo |
|  |  | Victor Dellovo |
|  |  | Chief Executive Officer, |
|  |  | President and Director |
| May 7, 2026 | By: | /s/ Gary W. Levine |
|  |  | Gary W. Levine |
|  |  | Chief Financial Officer |

---

## Exhibit 10.2

**Exhibit 10.2**

---

| | |
|:---|:---|
| ![Graphic](cspi-20260331xex10d2001.jpg) | 175 Cabot Street – Suite 210<br>Lowell, MA 01854 USA<br>www.cspi.com<br>NASDAQ: CSPI |

---

January 2, 2026

Dear Eric:

On behalf of CSPI, I am pleased to confirm our offer to you for the position of Vice President of Finance and Chief Accounting Officer reporting to me. We believe your skills will add a lot to the CSPI team.

You will be paid a base salary of $7,500 per bi-weekly payroll (annualized at $195,000). We would expect you to begin working with us on January 24, 2026, or a mutual starting date that works for both of us.

Your compensation also includes an exceptional benefits program which currently includes cost shared health and dental insurance, company paid life, AD&D insurance, short and long-term disability income protection, long term care insurance, a 401(k) plan and Employee Stock Purchase Plan as well as auto insurance discounts. Your vacation benefits will be based on a two week accrual. Enclosed for your review is a summary of our current benefit offering.

Subject to approval of the Board of Directors, the company will award you a Restricted Stock Award (RSA) of 8,000 shares of restricted common stock of the company which vest over four years on the award date. The award shall be subject to all term as set forth in the 2025 CSPI Incentive Stock Plan.

You also will be eligible to participate in the Executive Bonus Plan or the TS bonus plan. If the company meets its financial goal (85%), and you meet the Key Performance Indicator(15%) will receive a bonus of 30% of your annual salary. The TS Bonus plan is explained on the attached sheet. The bonuses will be prorated based on the period of employment.

As a condition of employment, within the first three days, you will be required to sign an Employee Invention and Non-Disclosure Agreement and complete an Employment Verification Form (Form I-9) by providing appropriate identity and work authorization documents as required by the U.S. Department of Justice. The most common forms of ID are a passport or a driver's license <u>and</u> a birth certificate.

Eric, we look forward to welcoming you as a member of the CSPI team. Please confirm your acceptance by signing and scan one copy of this letter and return it to me. If you have any questions, please feel free to call me at 978-954-5040.

Sincerely,

/s/ Gary Levine

Gary W. Levine

CFO

---

| | | | |
|:---|:---|:---|:---|
| \<br>|  |  |  |
| Accepted by: | /s/ Eric Sachs | Date: | 1/7/2026 |

---

![Graphic](cspi-20260331xex10d2002.jpg)

------

## Exhibit 31.1

**Exhibit 31.1**

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Victor Dellovo, certify that:

1. I have reviewed this quarterly report on Form 10-Q of CSP Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| Ugust 7<br>|
| May 7, 2026 |
| /s/ Victor Dellovo |
| Victor Dellovo |
| Chief Executive Officer; |
| President and Director |

---

------

## Exhibit 31.2

**Exhibit 31.2**

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Gary W. Levine, certify that:

1. I have reviewed this quarterly report on Form 10-Q of CSP Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| May 7, 2026 |
| /s/Gary W. Levine |
| Gary W. Levine |
| Chief Financial Officer |

---

------

## Exhibit 32.1

**Exhibit 32.1**

**18 U.S.C. Section 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of CSP Inc. (the "Company") for the period ended March 31, 2026, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned Chief Executive Officer, President and Chairman and Chief Financial Officer of the Company, certifies, to the best knowledge and belief of the signatory, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| May 7, 2026 | By:  | /s/ Victor Dellovo |
|  |  | Victor Dellovo |
|  |  | Chief Executive Officer; |
|  |  | President and Director |
| May 7, 2026 | By:  | /s/ Gary W. Levine |
|  |  | Gary W. Levine |
|  |  | Chief Financial Officer |

---

------